<SEC-DOCUMENT>0001193125-26-012028.txt : 20260114
<SEC-HEADER>0001193125-26-012028.hdr.sgml : 20260114
<ACCEPTANCE-DATETIME>20260113200717
ACCESSION NUMBER:		0001193125-26-012028
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20260109
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260114
DATE AS OF CHANGE:		20260113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arcadia Biosciences, Inc.
		CENTRAL INDEX KEY:			0001469443
		STANDARD INDUSTRIAL CLASSIFICATION:	CRUDE PETROLEUM & NATURAL GAS [1311]
		ORGANIZATION NAME:           	01 Energy & Transportation
		EIN:				810571538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37383
		FILM NUMBER:		26531236

	BUSINESS ADDRESS:	
		STREET 1:		5956 SHERRY LANE
		STREET 2:		SUITE 2000
		CITY:			DALLAS
		STATE:			TX
		BUSINESS PHONE:		214-974-8921

	MAIL ADDRESS:	
		STREET 1:		5956 SHERRY LANE
		STREET 2:		SUITE 2000
		CITY:			DALLAS
		STATE:			TX
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>rkda-20260109.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-01-13T20:05:52.8313+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:rkda="http://arcadiabio.com/20260109" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html"/>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_016d44f7-8e4e-47fd-a84a-71dd3c120033" name="dei:EntityCentralIndexKey" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4">0001469443</ix:nonNumeric><ix:nonNumeric id="F_1378254f-7a4b-48e6-92df-9bcbfc2b4d37" name="dei:AmendmentFlag" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="rkda-20260109.xsd"/></ix:references><ix:resources><xbrli:context id="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001469443</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-09</xbrli:startDate><xbrli:endDate>2026-01-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">UNITED STATES<br/>SECURITIES AND EXCHANGE COMMISSION<br/></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><h2 style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_81558ed6-a658-4a6c-877a-e6e9697a2926" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8-K</span></ix:nonNumeric></span></h2><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">CURRENT REPORT</span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_9fd45f20-e91e-4550-9a0a-847856062738" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">January 09, 2026</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1d8ab472-4064-4d86-8457-871634151034" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Arcadia Biosciences, Inc.</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:20%;box-sizing:content-box;"/>
     <td style="width:18%;box-sizing:content-box;"/>
     <td style="width:41%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_a04774ce-bd1e-4418-b50c-0302d95bdfc4" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_c8f0e95b-9f5c-4c3a-8f91-ba5d9c083191" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">001-37383</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_d3efd588-8b83-4baf-838e-6b4fefb56853" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">81-0571538</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(State or Other Jurisdiction<br/>of Incorporation)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Commission File Number)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(IRS Employer<br/>Identification No.)</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_9dfee375-b870-4c5a-860f-e73583af113d" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">5956 Sherry Lane</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_ee8dd85e-2c7f-444d-87da-065ddb7d82fa" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Suite 2000</span></ix:nonNumeric></span></p></td>
     <td colspan="2" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_55940f47-668f-41d2-a575-3afc441352dd" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Dallas</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_6766d6d7-b6d6-4d76-9695-c821ce83fb7f" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Texas</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:bottom;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_55baaddc-6ec0-45c9-8e9b-d72a977e7d9e" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">75225</span></ix:nonNumeric></span></p></td>
    </tr>
    <tr style="height:7pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td colspan="3" style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">(Zip Code)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.398%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Registrant&#8217;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_b4f3aac5-e9ee-413d-9960-038811043e69" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">214</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_927d1112-d9ac-45d9-b3a1-8b6916b730a3" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">974-8921</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"/>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;text-align:left;">
     <td style="padding-top:0.125in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p><p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:3pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e984d6a9-9639-4103-be95-f9063996651c" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_177ab029-9d2e-4aaf-9437-1399689656a5" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1bb44dca-b500-4cb8-94cf-19609ab14f8b" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4d3e5752-1ffc-465e-a4d8-26f8d69d544c" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:38%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:15%;box-sizing:content-box;"/>
     <td style="width:1%;box-sizing:content-box;"/>
     <td style="width:45%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Title of each class</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Trading<br/>Symbol(s)</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid #ffffff03;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;"><br/>Name of each exchange on which registered</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_5b3c12e2-3a25-465d-92aa-cd0c4eefe82e" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Common</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_965dbaae-557b-4a90-b144-6cc94be1c116" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">RKDA</span></ix:nonNumeric></span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_cb904015-1283-41d6-91bb-987b48763fcc" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">The Nasdaq Stock Market LLC</span></ix:nonNumeric></span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_1d1b879d-7fa0-4812-b324-688b41ebd0b5" contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p><p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 1.01 Entry into a Material Definitive Agreement.</span></h2><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 9, 2026, Arcadia Biosciences, Inc. (the &#8220;Company&#8221;) entered into inducement offer letter agreements (the &#8220;Inducement Letters&#8221;) with certain investors (the &#8220;Participating Holders&#8221;) pursuant to which such Participating Holders agreed to exercise certain outstanding preferred investment options to purchase an aggregate of 808,595 shares of the Company&#8217;s common stock ("Common Stock"). The preferred investment options subject to the Inducement Letters had an exercise price of $9.00 per share and were originally issued in December 2020, January 2021, August 2022, and March 2023 (the &#8220;Existing Options&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the Inducement Letters, the Participating Holders agreed to exercise for cash the Existing Options at a reduced exercise price of $2.575 per share, in consideration for the Company&#8217;s agreement to issue new unregistered preferred investment options (the &#8220;New Options&#8221;) to purchase up to 1,617,190 shares of Common Stock. The New Options have an exercise price of $2.325 per share, are exercisable immediately upon issuance, and expire on the date that is 30 months following the effective date of the Resale Registration Statement described below (the &#8220;Option Termination Date&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The closing of the transactions contemplated by the Inducement Letters occurred on January 12, 2026 (the "Closing Date"). The Company received aggregate gross proceeds of approximately $2.1 million from the exercise of the Existing Options by the Participating Holders, before deducting placement agent fees and other offering expenses payable by the Company. The Company intends to use the net proceeds for working capital and general corporate purposes.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company engaged H.C. Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;) to act as its exclusive placement agent in connection with the transactions described above. In consideration for its services, the Company paid Wainwright a cash fee equal to 7.0% of the aggregate gross proceeds received from the exercise of the Existing Options. In addition, the Company paid Wainwright a management fee equal to 1.0% of the aggregate gross exercise price paid in cash and reimbursed Wainwright for certain expenses, including but not limited to $50,000 for legal expenses and $25,000 for non-accountable expenses.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company also issued to Wainwright or its designees placement agent preferred investment options (the &#8220;Placement Agent Options&#8221;) to purchase that number of shares of Common Stock ("Placement Agent Option Shares") equal to 7.0% of the aggregate number of shares of Common Stock underlying the Existing Options exercised in the transaction, or 56,602 shares. The Placement Agent Options have substantially the same terms as the New Options with the exception of an exercise price of $3.2188 per share, and have a term expiring on the Option Termination Date.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The resale of the shares of Common Stock underlying the Existing Options has been registered pursuant to registration statements on Form S-1 (File Nos. 333-262407 and 333-267637) and Form S-3 (File 333-252659 and 333-271082) (the &#8220;Registration Statements&#8221;).</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The New Options and Placement Agent Options are exercisable, at the option of each holder, in whole or in part, by delivering a duly executed exercise notice accompanied by payment in full for the number of shares of Common Stock purchased upon such exercise (except in the case of a cashless exercise). A holder (together with their affiliates) may not exercise any portion of the holder's New Options or Placement Agent Options to the extent that the holder would beneficially own more than 4.99% or 9.99% (as specified by the holder) of the outstanding Common Stock immediately after exercise (as such percentage is determined in accordance with the terms of the New Options and Placement Agent Options). Upon 61 days prior notice to the Company, the holder may increase or decrease the beneficial ownership limitation up to 9.99%.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company also agreed to file a registration statement covering the resale of the New Option Shares and Placement Agent Option Shares (the &#8220;Resale Registration Statement&#8221;) within 30 days after the Closing Date and to use commercially reasonable efforts to cause such Resale Registration Statement to be declared effective by the Securities and Exchange Commission (the "SEC") within 60 days following the date of the Inducement Letter (or within 90 days in certain circumstances). </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If, at the time a holder exercises its New Option or Placement Agent Option (as applicable), the Resale Registration Statement is not then effective or available, then in lieu of making the cash payment otherwise contemplated to be made upon such exercise in payment of the aggregate exercise price, the holder may elect instead to make a cashless net exercise and receive upon such exercise the net number of shares of Common Stock determined according to a formula set forth in the New Options and Placement Agent Options.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The exercise price and number of shares issuable upon exercise of the New Options or Placement Agent Options are subject to appropriate adjustment in the event of stock dividends, stock splits, subsequent rights offerings, pro rata distributions, reorganizations, or similar events. The New Options and the Placement Agent Options also contain customary provisions regarding adjustment of the exercise price and treatment upon certain kinds of fundamental transactions (as defined in the New Options and Placement Agent Options), including provisions providing for the receipt of alternative consideration or, in certain circumstances in connection with certain kinds of fundamental transactions, the ability for a holder to cause the Company to purchase the unexercised portion of the New Option or Placement Agent Option from the holder by paying to the holder an amount of cash equal to the Black Scholes value (calculated as provided in in the New Options and Placement Agent Options) of the remaining unexercised portion of the New Option or Placement Agent Option.</span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In the Inducement Letter, the Company agreed not to issue any shares of Common Stock or common stock equivalents or to file any other registration statement with the SEC (in each case, subject to certain exceptions) until 45 days after the Closing Date. The Company also agreed not to effect or agree to effect any variable rate transaction (as defined in the Inducement Letter) until one year after the Closing Date (subject to certain exceptions). </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Inducement Letter Agreement contains representations, warranties and covenants of the Company that the Company believes are typical for transactions of this type, and which were made solely for the benefit of the other signatories to the Inducement Letter.  The provisions of the Inducement Letter, including the representations and warranties contained therein, are not for the benefit of any party other than the party signatories thereto and are not intended for investors or the public to obtain factual information about the current state of affairs of the parties to the Inducement Letter.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The forms of the Inducement Letter, the New Options and the Placement Agent Options are attached as Exhibits 10.1, 4.1 and 4.2, respectively. The descriptions of the terms of the Inducement Letter, the New Options and the Placement Agent Options are not intended to be complete and are qualified in their entirety by reference to such exhibits.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </span></p><h2 style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3.02 Unregistered Sales of Equity Securities.</span></h2><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The information in Item 1.01 above is incorporated herein by reference. The offer and sale by the Company of the Shares, the New Options, the Placement Agent Options, New Option Shares and Placement Option Shares described in Item 1.01 have not been registered under the Securities Act of 1933, as amended (the "Securities Act") and such securities were offered in a private placement transaction pursuant to the exemption from registration provided in Section 4(a)(2) under the Securities Act and Rule 506(b) promulgated thereunder, as sales to accredited investors. Such securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act and any applicable state securities laws.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Neither this Current Report on Form 8-K nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy our securities nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</span></p><h2 style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 3.03 Material Modification to Rights of Security Holders.</span></h2><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January 9, 2026, the Company agreed to reduce the exercise price for the Existing Options to $2.575 per share.</span></p><h2 style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 7.01 Regulation FD Disclosure.</span></h2><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">On January12, 2026, the Company issued a press release disclosing the Private Placement transaction referenced above. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information furnished in this Item 7.01, including Exhibit 99.1, is not deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act 1934, as amended, or otherwise subject to the liability of that section. This information will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates them by reference.</span></p><h2 style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></h2><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(d)	Exhibits</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="background-color:#ffffff;font-weight:bold;visibility:collapse;">
     <td style="width:11.02%;box-sizing:content-box;"/>
     <td style="width:1.56%;box-sizing:content-box;"/>
     <td style="width:87.42%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="border-top:0.25pt solid;padding-top:0.01in;border-right:0.25pt solid;border-left:0.25pt solid;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;border-bottom:1pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Exhibit No.</span></p></td>
     <td style="border-top:0.25pt solid;padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;border-bottom:1pt solid #ffffff03;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="border-top:0.25pt solid;padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:bottom;padding-bottom:0.01in;border-bottom:1pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Description</span></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;border-right:0.25pt solid;border-left:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.1</span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><a href="rkda-ex4_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of New Preferred Investment Option</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;border-right:0.25pt solid;border-left:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">4.4</span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><a href="rkda-ex4_4.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form of Placement Agent Preferred Investment Option</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;border-right:0.25pt solid;border-left:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">10.1</span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><a href="rkda-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Inducement Letter Agreement dated January 9, 2026</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;border-right:0.25pt solid;border-left:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">99.1</span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><a href="rkda-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Press release dated January 12, 2026</span></a></p></td>
    </tr>
    <tr style="height:10pt;background-color:#ffffff;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;border-right:0.25pt solid;border-left:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">104</span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#212529;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;border-right:0.25pt solid;padding-left:0.01in;vertical-align:top;padding-bottom:0.01in;border-bottom:0.25pt solid;padding-right:0.01in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
  <div style="z-index:2;min-height:0.5in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">SIGNATURES</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:6%;box-sizing:content-box;"/>
     <td style="width:44%;box-sizing:content-box;"/>
     <td style="width:4%;box-sizing:content-box;"/>
     <td style="width:46%;box-sizing:content-box;"/>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">ARCADIA BIOSCIENCES, INC.</span></p></td>
    </tr>
    <tr style="word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Date:</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">January 13, 2026</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:0.25pt solid;padding-right:0in;"><p style="font-size:10pt;margin-top:4.3pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">/s/ THOMAS J. SCHAEFER</span></p></td>
    </tr>
    <tr style="height:10pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</span></p></td>
     <td style="padding-top:0.01in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:10pt;margin-top:0.7pt;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Thomas J. Schaefer, Chief Executive Officer</span></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</span></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;position:relative;"></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;"/>
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>rkda-ex4_1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-01-13T20:05:53.1256+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-4.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;SECURITIES ACT&#x201d;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.  THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PREFERRED INVESTMENT OPTION</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">arcadia biosciences, inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Shares: _______	Issue Date: January 12, 2026</font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Initial Exercise Date: January 12, 2026</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THIS PREFERRED INVESTMENT INVESTMENT OPTION (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investent Option</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) certifies that, for value received, _____________ or its assigns (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Initial Exercise Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and on or prior to 5:00 p.m. (New York City time) on on the date that is the thirty (30) month anniversary of the Effective Date, provided that, if such date is not a Trading Day, the date that is the immediately following Trading Day (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) but not thereafter, to subscribe for and purchase from Arcadia Biosciences, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), up to ______ shares (as subject to adjustment hereunder, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In addition to the terms defined elsewhere in this Preferred Investment Option, the following terms have the meanings indicated in this Section 1:</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the board of directors of the Company.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Business Day</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#x201c;stay at home&#x201d;, &#x201c;shelter-in-place&#x201d;,</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;non-essential employee&#x201d;  or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the United States Securities and Exchange Commission.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock Equivalents</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the date that the Resale Registration Statement (as defined in the Letter Agreement) has been declared effective by the Commission.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Letter Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means that certain letter agreement between the initial Holder hereof and the Company, dated as of January 9, 2026, pursuant to which such initial Holder agreed to exercise one or more preferred investment options to purchase shares of Common Stock and the Company agreed to issue to the initial Holder this Preferred Investment Option.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Options</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means this Preferred Investment Option and other preferred investment options issued by the Company pursuant to the Letter Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 144</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsidiary</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Day</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a day on which the Common Stock is traded on a Trading Market.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Market</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 28 Liberty Street, Floor 53, New York, NY 10005, and any successor transfer agent of the Company.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise of Preferred Investment Option</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Exercise of the purchase rights represented by this Preferred Investment Option may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Preferred Investment Option Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#x2019;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Preferred Investment Option to the Company until the Holder has purchased all of the Preferred Investment Option Shares available hereunder and the Preferred Investment Option has been exercised in full, in which case, the Holder shall surrender this Preferred Investment Option to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Preferred Investment Option resulting in purchases of a portion of the total number of Preferred Investment Option Shares available hereunder shall have the effect of lowering the outstanding number of Preferred Investment Option Shares purchasable hereunder in an amount equal to the applicable number of Preferred Investment Option Shares purchased.  The Holder and the Company shall maintain records showing the number of Preferred Investment Option Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice.  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Holder and any assignee, by acceptance of this Preferred Investment Option, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Preferred Investment Option Shares hereunder, the number of Preferred Investment Option Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The exercise price per share of Common Stock under this Preferred Investment Option shall be $2.325, subject to adjustment hereunder (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cashless Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If at the time of exercise hereof, there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of the Preferred Investment Option Shares by the Holder, then this Preferred Investment Option may also be exercised, in whole or in part, at such time by means of a &#x201c;cashless exercise&#x201d; in which the Holder shall be entitled to receive a number of Preferred Investment Option Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</font></div></div><p style="margin-left:13.333%;text-indent:-7.209%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#x201c;regular trading hours&#x201d; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&#x2019;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#x201c;regular trading hours&#x201d; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#x201c;regular trading hours&#x201d; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#x201c;regular trading hours&#x201d; on such Trading Day;</font></p><p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(B) = the Exercise Price of this Preferred Investment Option, as adjusted hereunder; and</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:13.333%;text-indent:-7.209%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(X) = the number of Preferred Investment Option Shares that would be issuable upon exercise of this Preferred Investment Option in accordance with the terms of this Preferred Investment Option if such exercise were by means of a cash exercise rather than a cashless exercise.</font></p><p style="margin-left:13.333%;text-indent:-7.209%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Bid Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as mutually determined by the Company and the Holder, provided that, if the Company and the Holder are unable to agree upon the fair market value of such security, then the fair market value will be determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VWAP</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if the OTCQB Venture Market (&#x201c;OTCQB&#x201d;) or the OTCQX Best Market (&#x201c;OTCQX&#x201d;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&#x201c;Pink Market&#x201d;) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Preferred Investment Option Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Preferred Investment Option Shares shall take on the characteristics of the Preferred Investment Options being exercised, and the holding period of the Preferred Investment Option Shares being issued may be tacked on to the holding period of this Preferred Investment Option.  The Company agrees not to take any position contrary to this Section 2(c).</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mechanics of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">i.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivery of Preferred Investment Option Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Following delivery of the Notice of Exercise, the Company shall cause the Preferred Investment Option Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#x2019;s or its designee&#x2019;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DWAC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Preferred Investment Option Shares to or resale of the Preferred Investment </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Option Shares by the Holder or (B) the Preferred Investment Option Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Preferred Investment Options, and otherwise by physical delivery of a certificate, registered in the Company&#x2019;s share register in the name of the Holder or its designee, for the number of Preferred Investment Option Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Share Delivery Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Preferred Investment Option Shares with respect to which this Preferred Investment Option has been exercised, irrespective of the date of delivery of the Preferred Investment Option Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day after the delivery of the Notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery of the Notice of Exercise.  If the Holder has paid the aggregate Exercise Price (other than in the case of a cashless exercise) subject to a Notice of Exercise by the Preferred Investment Option Share Delivery Date and the Company fails for any reason to deliver to the Holder the Preferred Investment Option Shares subject to a Notice of Exercise by the Preferred Investment Option Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Preferred Investment Option Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Preferred Investment Option Share Delivery Date) for each Trading Day after such Preferred Investment Option Share Delivery Date until such Preferred Investment Option Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Preferred Investment Option remains outstanding and exercisable.  As used herein, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Standard Settlement Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the standard settlement period, expressed in a number of Trading Days, on the Company&#x2019;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">ii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivery of New Preferred Investment Options Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If this Preferred Investment Option shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Preferred Investment Option, at the time of delivery of the Preferred Investment Option Shares, deliver to the Holder a new Preferred Investment </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Option evidencing the rights of the Holder to purchase the unpurchased Preferred Investment Option Shares called for by this Preferred Investment Option, which new Preferred Investment Option shall in all other respects be identical with this Preferred Investment Option.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">iii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rescission Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If the Company fails to cause the Transfer Agent to transmit to the Holder the Preferred Investment Option Shares pursuant to Section 2(d)(i) by the Preferred Investment Option Share Delivery Date, then the Holder will have the right to rescind such exercise on or before the second Trading Day following delivery of such Preferred Investment Option Shares.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">iv.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation for Buy-In on Failure to Timely Deliver Preferred Investment Option Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Preferred Investment Option Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Preferred Investment Option Share Delivery Date (and the aggregate Exercise Price is paid on or before the Preferred Investment Option Share Delivery Date, other than in the case of a cashless exercise), and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#x2019;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Preferred Investment Option Shares which the Holder anticipated receiving upon such exercise (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Buy-In</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#x2019;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Preferred Investment Option Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Preferred Investment Option and equivalent number of Preferred Investment Option Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.  For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.  Nothing herein shall limit a Holder&#x2019;s right to pursue any other remedies available to it hereunder, </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#x2019;s failure to timely deliver shares of Common Stock upon exercise of the Preferred Investment Option as required pursuant to the terms hereof.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">v.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Fractional Shares or Scrip</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Preferred Investment Option.  As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">vi.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charges, Taxes and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Issuance of Preferred Investment Option Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Preferred Investment Option Shares, all of which taxes and expenses shall be paid by the Company, and such Preferred Investment Option Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that in the event that Preferred Investment Option Shares are to be issued in a name other than the name of the Holder, this Preferred Investment Option when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.  The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Preferred Investment Option Shares.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">vii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Closing of Books</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Preferred Investment Option, pursuant to the terms hereof.</font></div></div><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Exercise Limitations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.    The Company shall not effect any exercise of this Preferred Investment Option, and a Holder shall not have the right to exercise any portion of this Preferred Investment Option, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#x2019;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#x2019;s Affiliates (such Persons, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attribution Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Preferred Investment Option with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issuable upon (i) exercise of the remaining, nonexercised portion of this Preferred Investment Option beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other  Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.   To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Preferred Investment Option is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Preferred Investment Option is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#x2019;s determination of whether this Preferred Investment Option is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Preferred Investment Option is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.   In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.  For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#x2019;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Preferred Investment Option, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.  The &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beneficial Ownership Limitation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall be 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Preferred Investment Option.  The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Preferred Investment Option held by the Holder and the provisions of this Section 2(e) shall continue to apply.  Any increase in the Beneficial Ownership Limitation will not be effective until the 61</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">st</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> day after such notice is delivered to the Company.  The provisions of this paragraph shall be</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Preferred Investment Option.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock Dividends and Splits</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the Company, at any time while this Preferred Investment Option is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Preferred Investment Option), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Preferred Investment Option shall be proportionately adjusted such that the aggregate Exercise Price of this Preferred Investment Option shall remain unchanged.  Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#x2011;classification.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsequent Rights Offerings</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all the record holders of any class of shares of Common Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchase Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Preferred Investment Option (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (such date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rights Determination Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) (</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that to the extent that the Holder&#x2019;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until the earlier of (i) such time, if ever, as its right thereto would </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not result in the Holder exceeding the Beneficial Ownership Limitation and (ii) three months after the Rights Determination Date).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pro Rata Distributions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  During such time as this Preferred Investment Option is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to all holders of shares of Common Stock as a class, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), at any time after the issuance of this Preferred Investment Option, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Preferred Investment Option (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;" id="ole_link5"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fundamental Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If, at any time while this Preferred Investment Option is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, other than any such disposition of shares of common stock of Above Food Ingredients Inc., (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company</font><font id="ole_link6"></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, directly or indirectly, in one or more related transactions </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power of the common equity of the Company (each a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fundamental Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), then, upon any subsequent exercise of </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">this Preferred Investment Option, the Holder shall have the right to receive, for each Preferred Investment Option Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Preferred Investment Option), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Alternate Consideration</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Preferred Investment Option is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Preferred Investment Option).  For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.  If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Preferred Investment Option following such Fundamental Transaction.  Notwithstanding anything to the contrary, in the event of a Fundamental Transaction in which both (i) the holders of the voting securities of the Company as of immediately prior to such Fundamental Transaction will not, following such Fundamental Transaction, directly or indirectly own more than 50% of the voting securities of the surviving entity or Successor Entity (as defined below), as applicable, and (ii) the Company is not the Successor Entity or does not continue as a reporting issuer under the Exchange Act ((i) and (ii), the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Buy-back Conditions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Company or any Successor Entity (as defined below) shall, at the Holder&#x2019;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Preferred Investment Option from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Preferred Investment Option on the date of the consummation of such Fundamental Transaction; provided, however, that, if the Buy-back Conditions have been satisfied and (1) the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, or (2) the Alternate Consideration payable to holders of the Company&#x2019;s Common Stock in such Fundamental Transaction consists of equity securities of the Successor Entity (or its ultimate parent) that are quoted or listed on a nationally recognized securities exchange, then Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Preferred Investment Option, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">offered or paid any consideration in such Fundamental Transaction where the Buy-back Conditions have been satisfied, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction.  &#x201c;Black Scholes Value&#x201d; means the value of this Preferred Investment Option based on the Black-Scholes Option Pricing Model obtained from the &#x201c;OV&#x201d; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to 100%, (C) the underlying price per share used in such calculation shall be the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&#x2019;s election and (ii) the date of consummation of the Fundamental Transaction.  The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (such entity, or if the Company is the surviving or successor entity then the Company, referred to as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successor Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) to assume in writing all of the obligations of the Company under this Preferred Investment Option and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Preferred Investment Option a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Preferred Investment Option which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Preferred Investment Option (without regard to any limitations on the exercise of this Preferred Investment Option) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Preferred Investment Option immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Preferred Investment Option and the other Transaction Documents referring to the &#x201c;Company&#x201d; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Preferred Investment Option and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Calculations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div></div><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">f)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice to Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  </font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">i.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adjustment to Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Preferred Investment Option Shares and setting forth a brief statement of the facts requiring such adjustment. </font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">ii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice to Allow Exercise by Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Preferred Investment Option Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.  To the extent that any notice provided in this Preferred Investment Option constitutes, or </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.  The Holder shall remain entitled to exercise this Preferred Investment Option during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer of Preferred Investment Option</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transferability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Preferred Investment Option and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Preferred Investment Option at the principal office of the Company or its designated agent, together with a written assignment of this Preferred Investment Option substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.  Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Preferred Investment Option or Preferred Investment Options in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Preferred Investment Option evidencing the portion of this Preferred Investment Option not so assigned, and this Preferred Investment Option shall promptly be cancelled.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Preferred Investment Option to the Company unless the Holder has assigned this Preferred Investment Option in full, in which case, the Holder shall surrender this Preferred Investment Option to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Preferred Investment Option in full.  The Preferred Investment Option, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Preferred Investment Option Shares without having a new Preferred Investment Option issued.  </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New Preferred Investment Options</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Preferred Investment Option may be divided or combined with other Preferred Investment Options upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Preferred Investment Options are to be issued, signed by the Holder or its agent or attorney.  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Preferred Investment Option or Preferred Investment Options in exchange for the Preferred Investment Option or Preferred Investment Options to be divided or combined in accordance with such notice. All Preferred Investment Options issued on transfers or exchanges shall be dated the Issue Date of this Preferred Investment Option and shall be identical with this Preferred Investment Option except as to the number of Preferred Investment Option Shares issuable pursuant thereto. </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Register</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company shall register this Preferred Investment Option, upon records to be maintained by the Company for that purpose (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Register</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), in the name of the record Holder hereof from time to time.  The Company may deem and treat the registered Holder of this Preferred Investment Option as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Restrictions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If, at the time of the surrender of this Preferred Investment Option in connection with any transfer of this Preferred Investment Option, the transfer of this Preferred Investment Option shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Preferred Investment Option, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Representation by the Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Preferred Investment Option and, upon any exercise hereof, will acquire the Preferred Investment Option Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Preferred Investment Option Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Miscellaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Rights as Stockholder Until Exercise; No Settlement in Cash</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Preferred Investment Option does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.  Without limiting the rights of a Holder to receive Preferred Investment Option Shares on a &#x201c;cashless exercise,&#x201d; and to receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash settle a Preferred Investment Option exercise.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss, Theft, Destruction or Mutilation of Preferred Investment Option</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Preferred Investment Option or any stock certificate relating to the Preferred Investment Option Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Preferred Investment Option, shall not include the posting of any bond), and upon surrender and cancellation of such Preferred Investment Option or stock certificate, if mutilated, the Company will make and deliver a new Preferred Investment Option or stock certificate of like tenor and dated as of such cancellation, in lieu of such Preferred Investment Option or stock certificate.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Saturdays, Sundays, Holidays, etc</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Authorized Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  </font></div></div><p style="margin-left:13.333%;text-indent:15.385%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company covenants that, during the period the Preferred Investment Option is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Preferred Investment Option Shares upon the exercise of any purchase rights under this Preferred Investment Option.  The Company further covenants that its issuance of this Preferred Investment Option shall constitute full authority to its officers who are charged with the duty of issuing the necessary Preferred Investment Option Shares upon the exercise of the purchase rights under this Preferred Investment Option.  The Company will take all such reasonable action as may be necessary to assure that such Preferred Investment Option Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.  The Company covenants that all Preferred Investment Option Shares which may be issued upon the exercise of the purchase rights represented by this Preferred Investment Option will, upon exercise of the purchase rights represented by this Preferred Investment Option and payment for such Preferred Investment Option Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="margin-left:13.333%;text-indent:7.692%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Preferred Investment Option, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Preferred Investment Option against impairment.  Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Preferred Investment Option Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Preferred Investment Option Shares upon the exercise of this Preferred Investment Option and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Preferred Investment Option.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:13.333%;text-indent:7.692%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before taking any action which would result in an adjustment in the number of Preferred Investment Option Shares for which this Preferred Investment Option is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Jurisdiction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All questions concerning the construction, validity, enforcement and interpretation of this Preferred Investment Option shall be determined in accordance with the provisions of the Purchase Agreement.  </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">f)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restrictions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Holder acknowledges that the Preferred Investment Option Shares acquired upon the exercise of this Preferred Investment Option, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">g)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nonwaiver and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder or the Company shall operate as a waiver of such right or otherwise prejudice that party&#x2019;s rights, powers or remedies, notwithstanding the fact that the right to exercise this Preferred Investment Option terminates on the Termination Date.  Without limiting any other provision of this Preferred Investment Option or the Purchase Agreement, if either party willfully and knowingly fails to comply with any provision of this Preferred Investment Option, which results in any material damages to the other party, the first party shall pay such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#x2019; fees, including those of appellate proceedings, incurred by the affected party in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">h)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limitation of Liability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  No provision hereof, in the absence of any affirmative action by the Holder to exercise this Preferred Investment Option to purchase Preferred Investment Option Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">j)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Preferred Investment Option.  The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Preferred Investment Option and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">k)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successors and Assigns</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Subject to applicable securities laws, this Preferred Investment Option and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.  The provisions of this Preferred Investment Option are intended to be for the benefit of any Holder from time to time of this Preferred Investment Option and shall be enforceable by the Holder or holder of Preferred Investment Option Shares.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">l)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Other than Section 2(e) above and this Section 5(l), which may not be amended, modified or waived, this Preferred Investment Option may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">m)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Wherever possible, each provision of this Preferred Investment Option shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Preferred Investment Option shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Preferred Investment Option.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">n)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acceptance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Receipt of this Preferred Investment Option by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">o)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The headings used in this Preferred Investment Option are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Preferred Investment Option.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">********************</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(Signature Page Follows)</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, the Company has caused this Preferred Investment Option to be executed by its officer thereunto duly authorized as of the date first above indicated.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:63.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">arcadia biosciences, inc.</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:__________________________________________</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Name: Thomas J. Schaefer</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Title: Chief Executive Officer</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTICE OF EXERCISE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To:	arcadia biosciences, inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(1)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned hereby elects to purchase ________ Preferred Investment Option Shares of the Company pursuant to the terms of the attached Preferred Investment Option (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(2)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payment shall take the form of (check applicable box):</font></div></div><p style="margin-left:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[  ] in lawful money of the United States; or</font></p><p style="margin-left:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[  ] if permitted the cancellation of such number of Preferred Investment Option Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Preferred Investment Option with respect to the maximum number of Preferred Investment Option Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</font></p><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(3)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Please issue said Preferred Investment Option Shares in the name of the undersigned or in such other name as is specified below:</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			_______________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Preferred Investment Option Shares shall be delivered to the following DWAC Account Number:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			_______________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			_______________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			_______________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		(4)  In accordance with Section 2(e) of the Preferred Investment Option, after giving effect to the number of Preferred Investment Option Shares issuable upon this exercise of the Preferred Investment Option, the undersigned will not beneficially own in excess of 4.99% (or 9.99%, if applicable in accordance with Section 2(e)) of the number of shares of Common Stock of the Company outstanding immediately after giving effect to the issuance of such Preferred Investment Option Shares.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		(</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5)  </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accredited Investor</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The undersigned is an &#x201c;accredited investor&#x201d; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[SIGNATURE OF HOLDER]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Investing Entity: ________________________________________________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Signature of Authorized Signatory of Investing Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: _________________________________________________</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Authorized Signatory: ___________________________________________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title of Authorized Signatory: ____________________________________________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: ________________________________________________________________________________________</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT B</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASSIGNMENT FORM</font></p><p style="text-indent:1.947%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> (To assign the foregoing Preferred Investment Option, execute this form and supply required information.  Do not use this form to exercise the Preferred Investment Option to purchase shares.)</font></p><p style="text-indent:1.947%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FOR VALUE RECEIVED, the foregoing Preferred Investment Option and all rights evidenced thereby are hereby assigned to</font></p>
   <table style="border-spacing:0;table-layout:auto;width:91.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Please Print)</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Address:</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Phone Number:</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Email Address:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Please Print)</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">______________________________________</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">______________________________________</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dated: _______________ __, ______</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Signature:</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:30pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Address:</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:30pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>3
<FILENAME>rkda-ex4_4.htm
<DESCRIPTION>EX-4.4
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-01-13T20:05:53.0549+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-4.4</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 4.4</font></p><p style="text-indent:-93.548%;padding-left:48.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;SECURITIES ACT&#x201d;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.  THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PLACEMENT AGENT PREFERRED INVESTMENT OPTION</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">arcadia biosciences, inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Shares: _______	Issue Date: January 12, 2026</font></p><p style="margin-left:46.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Initial Exercise Date: January 12, 2026</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">THIS PLACEMENT AGENT PREFERRED INVESTMENT INVESTMENT OPTION (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investent Option</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) certifies that, for value received, _____________ or its assigns (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Initial Exercise Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and on or prior to 5:00 p.m. (New York City time) on on the date that is the thirty (30) month anniversary of the Effective Date, provided that, if such date is not a Trading Day, the date that is the immediately following Trading Day (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Termination Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) but not thereafter, to subscribe for and purchase from Arcadia Biosciences, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), up to ______ shares (as subject to adjustment hereunder, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). The purchase price of one share of Common Stock under this Preferred Investment Option shall be equal to the Exercise Price, as defined in Section 2(b).  This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright &amp; Co., LLC, dated as of January 8. 2026 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Engagement Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Definitions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In addition to the terms defined elsewhere in this Preferred Investment Option, the following terms have the meanings indicated in this Section 1:</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Affiliate</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Board of Directors</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the board of directors of the Company.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Business Day</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by law to remain closed; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &#x201c;stay at home&#x201d;, &#x201c;shelter-in-place&#x201d;, &#x201c;non-essential employee&#x201d;  or any other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are open for use by customers on such day.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the United States Securities and Exchange Commission.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock Equivalents</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Effective Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the date that the Resale Registration Statement (as defined in the Letter Agreement) has been declared effective by the Commission.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exchange Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Person</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Options</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means this Preferred Investment Option and other preferred investment options issued by the Company pursuant to the Engagement Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rule 144</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsidiary</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any subsidiary of the Company and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Day</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a day on which the Common Stock is traded on a Trading Market.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Trading Market</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any successors to any of the foregoing).</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 28 Liberty Street, Floor 53, New York, NY 10005, and any successor transfer agent of the Company.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 2</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise of Preferred Investment Option</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Exercise of the purchase rights represented by this Preferred Investment Option may be made, in whole or in part, at any time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).  Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Preferred Investment Option Shares specified in the applicable Notice of Exercise by wire transfer or cashier&#x2019;s check drawn on a United States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Preferred Investment Option to the Company until the Holder has purchased all of the Preferred Investment Option Shares available hereunder and the Preferred Investment Option has been exercised in full, in which case, the Holder shall surrender this Preferred Investment Option to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Preferred Investment Option resulting in purchases of a portion of the total number of Preferred Investment Option Shares available hereunder shall have the effect of lowering the outstanding number of Preferred Investment Option Shares purchasable hereunder in an amount equal to the applicable number of Preferred Investment Option Shares purchased.  The Holder and the Company shall maintain records showing the number of Preferred Investment Option Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice.  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Holder and any assignee, by acceptance of this Preferred Investment Option, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Preferred Investment Option Shares hereunder, the number of Preferred Investment Option Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The exercise price per share of Common Stock under this Preferred Investment Option shall be </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">$3.2188</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, subject to adjustment hereunder (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Cashless Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If at the time of exercise hereof, there is no effective registration statement registering, or the prospectus contained therein is not available for the resale of the Preferred Investment Option Shares by the Holder, then this Preferred Investment Option may also be exercised, in whole or in part, at such time by means of a &#x201c;cashless exercise&#x201d; in which the Holder shall be entitled to receive a number of Preferred Investment Option Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</font></div></div><p style="margin-left:13.333%;text-indent:-7.209%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(A) = as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &#x201c;regular trading hours&#x201d; (as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder&#x2019;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &#x201c;regular trading hours&#x201d; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &#x201c;regular trading hours&#x201d; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &#x201c;regular trading hours&#x201d; on such Trading Day;</font></p><p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(B) = the Exercise Price of this Preferred Investment Option, as adjusted hereunder; and</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:13.333%;text-indent:-8.333%;padding-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:13.333%;text-indent:-7.209%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">(X) = the number of Preferred Investment Option Shares that would be issuable upon exercise of this Preferred Investment Option in accordance with the terms of this Preferred Investment Option if such exercise were by means of a cash exercise rather than a cashless exercise.</font></p><p style="margin-left:13.333%;text-indent:-7.209%;padding-left:5.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;Bid Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as mutually determined by the Company and the Holder, provided that, if the Company and the Holder are unable to agree upon the fair market value of such security, then the fair market value will be determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">VWAP</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)  if the OTCQB Venture Market (&#x201c;OTCQB&#x201d;) or the OTCQX Best Market (&#x201c;OTCQX&#x201d;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&#x201c;Pink Market&#x201d;) operated by the OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If Preferred Investment Option Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Preferred Investment Option Shares shall take on the characteristics of the Preferred Investment Options being exercised, and the holding period of the Preferred Investment Option Shares being issued may be tacked on to the holding period of this Preferred Investment Option.  The Company agrees not to take any position contrary to this Section 2(c).</font></p><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Mechanics of Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. </font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">i.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivery of Preferred Investment Option Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Following delivery of the Notice of Exercise, the Company shall cause the Preferred Investment Option Shares purchased hereunder to be transmitted by the Transfer Agent to the Holder by crediting the account of the Holder&#x2019;s or its designee&#x2019;s balance account with The Depository Trust Company through its Deposit or Withdrawal at Custodian system (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DWAC</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) if the Company is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the Preferred Investment Option Shares to or resale of the Preferred Investment </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Option Shares by the Holder or (B) the Preferred Investment Option Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant to Rule 144 (assuming cashless exercise of the Preferred Investment Options, and otherwise by physical delivery of a certificate, registered in the Company&#x2019;s share register in the name of the Holder or its designee, for the number of Preferred Investment Option Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise, and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Share Delivery Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Preferred Investment Option Shares with respect to which this Preferred Investment Option has been exercised, irrespective of the date of delivery of the Preferred Investment Option Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) one (1) Trading Day after the delivery of the Notice of Exercise and (ii) the number of Trading Days comprising the Standard Settlement Period after the delivery of the Notice of Exercise.  If the Holder has paid the aggregate Exercise Price (other than in the case of a cashless exercise) subject to a Notice of Exercise by the Preferred Investment Option Share Delivery Date and the Company fails for any reason to deliver to the Holder the Preferred Investment Option Shares subject to a Notice of Exercise by the Preferred Investment Option Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Preferred Investment Option Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Preferred Investment Option Share Delivery Date) for each Trading Day after such Preferred Investment Option Share Delivery Date until such Preferred Investment Option Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Preferred Investment Option remains outstanding and exercisable.  As used herein, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Standard Settlement Period</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the standard settlement period, expressed in a number of Trading Days, on the Company&#x2019;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">ii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delivery of New Preferred Investment Options Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If this Preferred Investment Option shall have been exercised in part, the Company shall, at the request of a Holder and upon surrender of this Preferred Investment Option, at the time of delivery of the Preferred Investment Option Shares, deliver to the Holder a new Preferred Investment </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Option evidencing the rights of the Holder to purchase the unpurchased Preferred Investment Option Shares called for by this Preferred Investment Option, which new Preferred Investment Option shall in all other respects be identical with this Preferred Investment Option.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">iii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rescission Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If the Company fails to cause the Transfer Agent to transmit to the Holder the Preferred Investment Option Shares pursuant to Section 2(d)(i) by the Preferred Investment Option Share Delivery Date, then the Holder will have the right to rescind such exercise on or before the second Trading Day following delivery of such Preferred Investment Option Shares.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">iv.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Compensation for Buy-In on Failure to Timely Deliver Preferred Investment Option Shares Upon Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In addition to any other rights available to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Preferred Investment Option Shares in accordance with the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Preferred Investment Option Share Delivery Date (and the aggregate Exercise Price is paid on or before the Preferred Investment Option Share Delivery Date, other than in the case of a cashless exercise), and if after such date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder&#x2019;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Preferred Investment Option Shares which the Holder anticipated receiving upon such exercise (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Buy-In</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&#x2019;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Preferred Investment Option Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion of the Preferred Investment Option and equivalent number of Preferred Investment Option Shares for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.  For example, if the Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss.  Nothing herein shall limit a Holder&#x2019;s right to pursue any other remedies available to it hereunder, </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&#x2019;s failure to timely deliver shares of Common Stock upon exercise of the Preferred Investment Option as required pursuant to the terms hereof.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">v.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Fractional Shares or Scrip</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Preferred Investment Option.  As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">vi.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Charges, Taxes and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Issuance of Preferred Investment Option Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Preferred Investment Option Shares, all of which taxes and expenses shall be paid by the Company, and such Preferred Investment Option Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that in the event that Preferred Investment Option Shares are to be issued in a name other than the name of the Holder, this Preferred Investment Option when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.  The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Preferred Investment Option Shares.</font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">vii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Closing of Books</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Preferred Investment Option, pursuant to the terms hereof.</font></div></div><p style="margin-left:6.667%;text-indent:7.143%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">e)	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Exercise Limitations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.    The Company shall not effect any exercise of this Preferred Investment Option, and a Holder shall not have the right to exercise any portion of this Preferred Investment Option, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&#x2019;s Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder&#x2019;s Affiliates (such Persons, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Attribution Parties</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).  For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Preferred Investment Option with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">issuable upon (i) exercise of the remaining, nonexercised portion of this Preferred Investment Option beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any other  Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.  Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith.   To the extent that the limitation contained in this Section 2(e) applies, the determination of whether this Preferred Investment Option is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Preferred Investment Option is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&#x2019;s determination of whether this Preferred Investment Option is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Preferred Investment Option is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.   In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder.  For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&#x2019;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.  Upon the written or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding.  In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Preferred Investment Option, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.  The &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beneficial Ownership Limitation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; shall be 4.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Preferred Investment Option.  The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of this Preferred Investment Option held by the Holder and the provisions of this Section 2(e) shall continue to apply.  Any increase in the Beneficial Ownership Limitation will not be effective until the 61</font><font style="color:#000000;white-space:pre-wrap;vertical-align:super;font-size:8.040000000000001pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">st</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> day after such notice is delivered to the Company.  The provisions of this paragraph shall be</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Preferred Investment Option.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 3</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certain Adjustments</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Stock Dividends and Splits</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If the Company, at any time while this Preferred Investment Option is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this Preferred Investment Option), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares or (iv) issues by reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Preferred Investment Option shall be proportionately adjusted such that the aggregate Exercise Price of this Preferred Investment Option shall remain unchanged.  Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re&#x2011;classification.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Subsequent Rights Offerings</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to all the record holders of any class of shares of Common Stock (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Purchase Rights</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Preferred Investment Option (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (such date, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Rights Determination Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) (</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that to the extent that the Holder&#x2019;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until the earlier of (i) such time, if ever, as its right thereto would </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">not result in the Holder exceeding the Beneficial Ownership Limitation and (ii) three months after the Rights Determination Date).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Pro Rata Distributions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  During such time as this Preferred Investment Option is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to all holders of shares of Common Stock as a class, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Distribution</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), at any time after the issuance of this Preferred Investment Option, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Preferred Investment Option (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">provided</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">however</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, that, to the extent that the Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;" id="ole_link6"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fundamental Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If, at any time while this Preferred Investment Option is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, exclusive license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, other than any such disposition of shares of common stock of Above Food Ingredients Inc., (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding Common Stock or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company</font><font id="ole_link5"></font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">, directly or indirectly, in one or more related transactions </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more than 50% of the voting power of the common equity of the Company (each a &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Fundamental Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), then, upon any subsequent exercise of </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">this Preferred Investment Option, the Holder shall have the right to receive, for each Preferred Investment Option Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Preferred Investment Option), the number of shares of Common Stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Alternate Consideration</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Preferred Investment Option is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Preferred Investment Option).  For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration.  If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Preferred Investment Option following such Fundamental Transaction.  Notwithstanding anything to the contrary, in the event of a Fundamental Transaction in which both (i) the holders of the voting securities of the Company as of immediately prior to such Fundamental Transaction will not, following such Fundamental Transaction, directly or indirectly own more than 50% of the voting securities of the surviving entity or Successor Entity (as defined below), as applicable, and (ii) the Company is not the Successor Entity or does not continue as a reporting issuer under the Exchange Act ((i) and (ii), the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Buy-back Conditions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), the Company or any Successor Entity (as defined below) shall, at the Holder&#x2019;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Preferred Investment Option from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Preferred Investment Option on the date of the consummation of such Fundamental Transaction; provided, however, that, if the Buy-back Conditions have been satisfied and (1) the Fundamental Transaction is not within the Company's control, including not approved by the Company's Board of Directors, or (2) the Alternate Consideration payable to holders of the Company&#x2019;s Common Stock in such Fundamental Transaction consists of equity securities of the Successor Entity (or its ultimate parent) that are quoted or listed on a nationally recognized securities exchange, then Holder shall only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Preferred Investment Option, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common Stock of the Company are not</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">offered or paid any consideration in such Fundamental Transaction where the Buy-back Conditions have been satisfied, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Successor Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction.  &#x201c;Black Scholes Value&#x201d; means the value of this Preferred Investment Option based on the Black-Scholes Option Pricing Model obtained from the &#x201c;OV&#x201d; function on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, (B) an expected volatility equal to 100%, (C) the underlying price per share used in such calculation shall be the sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (D) a remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&#x2019;s election and (ii) the date of consummation of the Fundamental Transaction.  The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (such entity, or if the Company is the surviving or successor entity then the Company, referred to as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successor Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) to assume in writing all of the obligations of the Company under this Preferred Investment Option and the other Transaction Documents in accordance with the provisions of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Preferred Investment Option a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Preferred Investment Option which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Preferred Investment Option (without regard to any limitations on the exercise of this Preferred Investment Option) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Preferred Investment Option immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Preferred Investment Option and the other Transaction Documents referring to the &#x201c;Company&#x201d; shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this Preferred Investment Option and the other Transaction Documents with the same effect as if such Successor Entity had been named as the Company herein.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">13</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Calculations</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</font></div></div><p style="margin-left:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:13.333%;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:3.8457544394060026%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">f)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice to Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  </font></div></div><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">i.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Adjustment to Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Preferred Investment Option Shares and setting forth a brief statement of the facts requiring such adjustment. </font></div></div><div class="item-list-element-wrapper" style="margin-left:20%;text-indent:8.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:6.33375%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:center;">ii.</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notice to Allow Exercise by Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall appear upon the Preferred Investment Option Register of the Company, at least 10 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.  To the extent that any notice provided in this Preferred Investment Option constitutes, or </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">14</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:20%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">contains, material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.  The Holder shall remain entitled to exercise this Preferred Investment Option during the period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 4</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer of Preferred Investment Option</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transferability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of Section 4.1 of the Purchase Agreement, this Preferred Investment Option and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole or in part, upon surrender of this Preferred Investment Option at the principal office of the Company or its designated agent, together with a written assignment of this Preferred Investment Option substantially in the form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer.  Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Preferred Investment Option or Preferred Investment Options in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Preferred Investment Option evidencing the portion of this Preferred Investment Option not so assigned, and this Preferred Investment Option shall promptly be cancelled.  Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Preferred Investment Option to the Company unless the Holder has assigned this Preferred Investment Option in full, in which case, the Holder shall surrender this Preferred Investment Option to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this Preferred Investment Option in full.  The Preferred Investment Option, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Preferred Investment Option Shares without having a new Preferred Investment Option issued.  </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New Preferred Investment Options</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. This Preferred Investment Option may be divided or combined with other Preferred Investment Options upon presentation hereof at the aforesaid office of the Company, together with a written notice specifying the names and denominations in which new Preferred Investment Options are to be issued, signed by the Holder or its agent or attorney.  Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Preferred Investment Option or Preferred Investment Options in exchange for the Preferred Investment Option or Preferred Investment Options to be divided or combined in accordance with such notice. All Preferred Investment Options issued on transfers or exchanges shall be dated the Issue Date of this Preferred Investment Option and shall be identical with this Preferred Investment Option except as to the number of Preferred Investment Option Shares issuable pursuant thereto. </font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">15</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Register</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company shall register this Preferred Investment Option, upon records to be maintained by the Company for that purpose (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Preferred Investment Option Register</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), in the name of the record Holder hereof from time to time.  The Company may deem and treat the registered Holder of this Preferred Investment Option as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Transfer Restrictions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. If, at the time of the surrender of this Preferred Investment Option in connection with any transfer of this Preferred Investment Option, the transfer of this Preferred Investment Option shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Preferred Investment Option, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Representation by the Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Preferred Investment Option and, upon any exercise hereof, will acquire the Preferred Investment Option Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling such Preferred Investment Option Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to sales registered or exempted under the Securities Act.</font></div></div><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Section 5</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.	</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Miscellaneous</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">a)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No Rights as Stockholder Until Exercise; No Settlement in Cash</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  This Preferred Investment Option does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set forth in Section 3.  Without limiting the rights of a Holder to receive Preferred Investment Option Shares on a &#x201c;cashless exercise,&#x201d; and to receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the Company be required to net cash settle a Preferred Investment Option exercise.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">b)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Loss, Theft, Destruction or Mutilation of Preferred Investment Option</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Preferred Investment Option or any stock certificate relating to the Preferred Investment Option Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Preferred Investment Option, shall not include the posting of any bond), and upon surrender and cancellation of such Preferred Investment Option or stock certificate, if mutilated, the Company will make and deliver a new Preferred Investment Option or stock certificate of like tenor and dated as of such cancellation, in lieu of such Preferred Investment Option or stock certificate.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">16</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">c)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Saturdays, Sundays, Holidays, etc</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">d)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Authorized Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  </font></div></div><p style="margin-left:13.333%;text-indent:15.385%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company covenants that, during the period the Preferred Investment Option is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of the Preferred Investment Option Shares upon the exercise of any purchase rights under this Preferred Investment Option.  The Company further covenants that its issuance of this Preferred Investment Option shall constitute full authority to its officers who are charged with the duty of issuing the necessary Preferred Investment Option Shares upon the exercise of the purchase rights under this Preferred Investment Option.  The Company will take all such reasonable action as may be necessary to assure that such Preferred Investment Option Shares may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed.  The Company covenants that all Preferred Investment Option Shares which may be issued upon the exercise of the purchase rights represented by this Preferred Investment Option will, upon exercise of the purchase rights represented by this Preferred Investment Option and payment for such Preferred Investment Option Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="margin-left:13.333%;text-indent:7.692%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Except and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Preferred Investment Option, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Preferred Investment Option against impairment.  Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Preferred Investment Option Shares above the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Preferred Investment Option Shares upon the exercise of this Preferred Investment Option and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Preferred Investment Option.</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">17</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="margin-left:13.333%;text-indent:7.692%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Before taking any action which would result in an adjustment in the number of Preferred Investment Option Shares for which this Preferred Investment Option is exercisable or in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof.</font></p><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">e)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Jurisdiction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. All questions concerning the construction, validity, enforcement and interpretation of this Preferred Investment Option shall be determined in accordance with the provisions of the Purchase Agreement.  </font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">f)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Restrictions</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Holder acknowledges that the Preferred Investment Option Shares acquired upon the exercise of this Preferred Investment Option, if not registered and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">g)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Nonwaiver and Expenses</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder or the Company shall operate as a waiver of such right or otherwise prejudice that party&#x2019;s rights, powers or remedies, notwithstanding the fact that the right to exercise this Preferred Investment Option terminates on the Termination Date.  Without limiting any other provision of this Preferred Investment Option or the Purchase Agreement, if either party willfully and knowingly fails to comply with any provision of this Preferred Investment Option, which results in any material damages to the other party, the first party shall pay such amounts as shall be sufficient to cover any costs and expenses including, but not limited to, reasonable attorneys&#x2019; fees, including those of appellate proceedings, incurred by the affected party in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">h)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notices</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in accordance with the notice provisions of the Purchase Agreement.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Limitation of Liability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  No provision hereof, in the absence of any affirmative action by the Holder to exercise this Preferred Investment Option to purchase Preferred Investment Option Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">j)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Remedies</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific performance of its rights under this Preferred Investment Option.  The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Preferred Investment Option and hereby agrees to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.</font></div></div></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">18</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">k)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Successors and Assigns</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Subject to applicable securities laws, this Preferred Investment Option and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.  The provisions of this Preferred Investment Option are intended to be for the benefit of any Holder from time to time of this Preferred Investment Option and shall be enforceable by the Holder or holder of Preferred Investment Option Shares.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">l)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Other than Section 2(e) above and this Section 5(l), which may not be amended, modified or waived, this Preferred Investment Option may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">m)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Severability</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Wherever possible, each provision of this Preferred Investment Option shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Preferred Investment Option shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Preferred Investment Option.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">n)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Acceptance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  Receipt of this Preferred Investment Option by the Holder shall constitute acceptance of and agreement to all of the terms and conditions contained herein.</font></div></div><div class="item-list-element-wrapper" style="margin-left:6.667%;text-indent:7.143%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:6.667%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:5.14287551026968%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">o)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Headings</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The headings used in this Preferred Investment Option are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Preferred Investment Option.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">********************</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">(Signature Page Follows)</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">19</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="z-index:2;min-height:1in;position:relative;"></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:13.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">IN WITNESS WHEREOF, the Company has caused this Preferred Investment Option to be executed by its officer thereunto duly authorized as of the date first above indicated.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:63.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:100%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">arcadia biosciences, inc.</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:__________________________________________</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Name: Thomas J. Schaefer</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;&#160;&#160;&#160;&#160;Title: Chief Executive Officer</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">20</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">NOTICE OF EXERCISE</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">To:	arcadia biosciences, inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(1)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The undersigned hereby elects to purchase ________ Preferred Investment Option Shares of the Company pursuant to the terms of the attached Preferred Investment Option (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</font></div></div><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(2)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Payment shall take the form of (check applicable box):</font></div></div><p style="margin-left:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[  ] in lawful money of the United States; or</font></p><p style="margin-left:20%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[  ] if permitted the cancellation of such number of Preferred Investment Option Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise this Preferred Investment Option with respect to the maximum number of Preferred Investment Option Shares purchasable pursuant to the cashless exercise procedure set forth in subsection 2(c).</font></p><div class="item-list-element-wrapper" style="text-indent:13.333%;font-size:0;margin-top:0;justify-content:flex-start;margin-bottom:12pt;min-width:13.333%;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4.8%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(3)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Please issue said Preferred Investment Option Shares in the name of the undersigned or in such other name as is specified below:</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			_______________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Preferred Investment Option Shares shall be delivered to the following DWAC Account Number:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			_______________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			_______________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">			_______________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		(4)  In accordance with Section 2(e) of the Preferred Investment Option, after giving effect to the number of Preferred Investment Option Shares issuable upon this exercise of the Preferred Investment Option, the undersigned will not beneficially own in excess of 4.99% (or 9.99%, if applicable in accordance with Section 2(e)) of the number of shares of Common Stock of the Company outstanding immediately after giving effect to the issuance of such Preferred Investment Option Shares.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">		(</font><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5)  </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accredited Investor</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">.  The undersigned is an &#x201c;accredited investor&#x201d; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[SIGNATURE OF HOLDER]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Investing Entity: ________________________________________________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Signature of Authorized Signatory of Investing Entity</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: _________________________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Authorized Signatory: ___________________________________________________________________</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.21in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title of Authorized Signatory: ____________________________________________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Date: ________________________________________________________________________________________</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.21in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.25in;z-index:2;min-height:0.5in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">EXHIBIT B</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">ASSIGNMENT FORM</font></p><p style="text-indent:1.947%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;"> (To assign the foregoing Preferred Investment Option, execute this form and supply required information.  Do not use this form to exercise the Preferred Investment Option to purchase shares.)</font></p><p style="text-indent:1.947%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">FOR VALUE RECEIVED, the foregoing Preferred Investment Option and all rights evidenced thereby are hereby assigned to</font></p>
   <table style="border-spacing:0;table-layout:auto;width:91.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:50%;box-sizing:content-box;"></td>
     <td style="width:50%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Please Print)</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Address:</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Phone Number:</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Email Address:</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">(Please Print)</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">______________________________________</font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">______________________________________</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Dated: _______________ __, ______</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Signature:</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;word-break:break-word;white-space:pre-wrap;text-align:right;">
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:30pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Holder&#x2019;s Address:</font></p></td>
     <td style="padding-top:0in;padding-left:0.075in;vertical-align:top;padding-bottom:0in;padding-right:0.075in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:30pt;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.21in;min-height:0.4in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>rkda-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-01-13T20:05:52.9282+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit 10.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Arcadia Biosciences, Inc.</font></p><p style="margin-left:60%;text-indent:16.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:60.84%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">January 9, 2026</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">          </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder of Preferred Investment Options</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:3.34%;box-sizing:content-box;"></td>
     <td style="width:96.66%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Re:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Inducement Offer to Exercise Preferred Investment Options</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Dear Holder:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Arcadia Biosciences, Inc. (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) is pleased to offer to you (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;, &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">you</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; or similar terminology) (i) the opportunity to receive new preferred investment options to purchase shares of the Company&#x2019;s common stock, par value $0.001 per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and (ii) a reduction in the Exercise Price (as defined in the respective Existing PIOs) of the preferred investment options set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereto (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Existing PIOs</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) held by you in consideration for exercising by you for cash all of the Existing PIOs, as set forth on the signature page hereto. The resale of the shares of Common Stock underlying the Existing PIOs (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Existing PIO Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) has been registered pursuant to the registration statements on Form S-1 (File Nos. 333-262407 and 333-267637) and Form S-3 (File 333-252659 and 333-271082) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Registration Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). The Registration Statements are currently effective and, upon exercise of the Existing PIOs pursuant to this letter agreement, will be effective for the issuance or resale of the Existing PIO Shares. Capitalized terms not otherwise defined herein shall have the meanings set forth in the New PIOs (as defined herein).</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company desires to reduce the Exercise Price (as defined in the respective Existing PIOs) of the Existing PIOs to $2.575 per share (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Reduced Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;). In consideration for the exercise in full for cash of all of the Existing PIOs held by the Holder at the Reduced Exercise Price as set forth on the Holder&#x2019;s signature page hereto (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PIO Exercise</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) on or before the Execution Time (as defined below), the Company hereby offers to sell and issue you new unregistered preferred investment options (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New PIOs</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), to purchase up to a number of shares (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New PIO Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) of Common Stock equal to 200% of the number of Preferred Investment Option Shares issued pursuant to the PIO Exercise hereunder, which New PIOs shall have an exercise price per share equal to $2.325, subject to adjustment as provided in the New PIOs, will be exercisable immediately and have a term of exercise of thirty (30) months after the Effective Date, which New PIOs shall be substantially in the form as set forth in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exhibit A-1</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> hereto.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The New PIO certificate(s) will be delivered at Closing (as defined below), and such New PIOs, together with any underlying shares of Common Stock issued upon exercise of the New PIOs, will, unless and until their sales are registered under the Securities Act, contain customary restrictive legends and other language typical for an unregistered preferred investment option and unregistered shares. Notwithstanding anything herein to the contrary, in the event that any PIO Exercise would otherwise cause the Holder to exceed the beneficial ownership limitations (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Beneficial Ownership Limitation</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) set forth in Section 2(e) of the Existing PIOs (or, if applicable</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">and at the Holder&#x2019;s election, 9.99%), the Company shall only issue such number of Existing PIO Shares to the Holder that would not cause the Holder to exceed the maximum number of Preferred Investment Option Shares permitted thereunder, as directed by the Holder, with the balance to be held in abeyance until notice from the Holder that the balance (or portion thereof) may be issued in compliance with such limitations, which abeyance shall be evidenced through the Existing PIOs which shall be deemed prepaid thereafter (including the cash payment in full of the exercise price), and exercised pursuant to a Notice of Exercise in the Existing PIOs (provided no additional exercise price shall be due and payable). The parties hereby agree that the Beneficial Ownership Limitation for purposes of the Existing PIOs is as set forth on the Holder&#x2019;s signature page hereto.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Expressly subject to the paragraph immediately following this paragraph below, Holder may accept this offer by signing this letter agreement below, with such acceptance constituting Holder&#x2019;s exercise in full of the Existing PIOs for an aggregate exercise price set forth on the Holder&#x2019;s signature page hereto (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">PIO Exercise Price</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) on or before 3:59 p.m., Eastern Time, on January 9, 2026 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Execution Time</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;).</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Additionally, the Company agrees to the representations, warranties and covenants set forth on </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annex A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> attached hereto. Holder represents and warrants that, as of the date hereof it is, and on each date on which it exercises any New PIOs it will be, an &#x201c;accredited investor&#x201d; as defined in Rule 501 of Regulation D promulgated under the Securities Act, and agrees that the New PIOs will contain restrictive legends when issued, and neither the New PIOs nor the shares of Common Stock issuable upon exercise of the New PIOs will be registered under the Securities Act, except as provided in </font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annex A</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> attached hereto. Also, Holder represents and warrants that it is acquiring the New PIOs as principal for its own account and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of the New PIOs or the New PIO Shares (this representation is not limiting Holder&#x2019;s right to sell the New PIO Shares pursuant to an effective registration statement under the Securities Act or otherwise in compliance with applicable federal and state securities laws).</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Holder understands that issuance of the New PIOs and the New PIO Shares are not, and may never be, registered under the Securities Act, or the securities laws of any state and, accordingly, each certificate, if any, representing such securities shall bear a legend substantially similar to the following:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="margin-left:3.333%;text-indent:6.897%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201c;THE OFFER AND SALE OF THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &#x201c;SECURITIES ACT&#x201d;), AND, ACCORDINGLY, THIS SECURITY MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.&#x201d;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">2</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Certificates evidencing the New PIO Shares shall not contain any legend (including the legend set forth above), (i) while a registration statement covering the resale of such New PIO Shares is effective under the Securities Act, (ii) following any sale of such New PIO Shares pursuant to Rule 144 under the Securities Act, (iii) if such New PIO Shares are eligible for sale under Rule 144 (assuming cashless exercise of the New PIOs), without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such New PIO Shares and without volume or manner-of-sale restrictions, (iv) if such New PIO Shares may be sold under Rule 144 (assuming cashless exercise of the New PIOs) and the Company is then in compliance with the current public information required under Rule 144 as to such New PIO Shares, or (v) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) and the earliest of clauses (i) through (v), the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Delegend Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;)). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent promptly after the Delegend Date if required by the Company and/or the Transfer Agent to effect the removal of the legend hereunder, or at the request of the Holder, which opinion shall be in form and substance reasonably acceptable to the Holder. From and after the Delegend Date, such New PIO Shares shall be issued free of all legends. The Company agrees that following the Delegend Date or at such time as such legend is no longer required under this Section, it will, no later than one (1) Trading Day following the delivery by the Holder to the Company or the Transfer Agent of a certificate representing the New PIO Shares issued with a restrictive legend (such first (1st) Trading Day, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Legend Removal Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), deliver or cause to be delivered to the Holder a certificate representing such shares that is free from all restrictive and other legends or, at the request of the Holder shall credit the account of the Holder&#x2019;s prime broker with the Depository Trust Company System as directed by the Holder.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">In addition to the Holder&#x2019;s other available remedies, the Company shall pay to a Holder, in cash, (i) as partial liquidated damages and not as a penalty, for each $1,000 of New PIO Shares (based on the VWAP of the Common Stock on the date such New PIO Shares are submitted to the Transfer Agent) delivered for removal of the restrictive legend, $10 per Trading Day (increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered) to the Holder by the Legend Removal Date a certificate representing the New PIO Shares that is free from all restrictive and other legends and (b) if after the Legend Removal Date the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that the Holder anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of the Holder&#x2019;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) over the product of (A) such number of New PIO Shares that the Company was required to deliver to the Holder by the Legend Removal Date and for which the Holder was required to purchase shares to timely satisfy delivery requirements, multiplied by (B) the weighted average price at which the Holder sold that number of shares of Common Stock.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">3</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">If this offer is accepted and the transaction documents are executed by the Execution Time, then as promptly as possible following the Execution Time, but in any event no later than 8:00 a.m., Eastern Time, on the Trading Day following the date hereof, the Company shall issue a press release disclosing the material terms of the transactions contemplated hereby and shall file a Current Report on Form 8-K with the Commission disclosing all material terms of the transactions contemplated hereunder, including the filing with the Commission of this letter agreement as an exhibit thereto within the time required by the Exchange Act. From and after the dissemination of such press release, the Company represents to you that it shall have publicly disclosed all material, non-public information delivered to you by the Company, or any of its respective officers, directors, employees or agents in connection with the transactions contemplated hereunder. In addition, effective upon the dissemination of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and you and your Affiliates on the other hand, shall terminate. The Company represents, warrants and covenants that, upon acceptance of this offer, the Existing PIO Shares shall be issued at Closing free of any legends or restrictions on resale by Holder.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">No later than the first (1st) Trading Day following the date of the public disclosure of the transactions hereunder, the closing (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Closing</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) shall occur at such location as the parties shall mutually agree. Unless otherwise directed by H.C. Wainwright &amp; Co., LLC (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Placement Agent</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), settlement of the Existing PIO Shares shall occur via &#x201c;Delivery Versus Payment&#x201d; (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DVP</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) (i.e., on the Closing Date (as defined below), the Company shall issue the Existing PIO Shares registered in the Holder&#x2019;s name and address provided to the Company in writing and released by the Transfer Agent directly to the account(s) at the Placement Agent identified by the Holder; upon receipt of such Existing PIO Shares, the Placement Agent shall promptly electronically deliver such Existing PIO Shares to the Holder, and payment therefor shall concurrently be made to the Company by the Placement Agent (or its clearing firm) by wire transfer to the Company). The date of the Closing of the PIO Exercise shall be referred to as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Closing Date</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company acknowledges and agrees that the obligations of the Holders under this letter agreement are several and not joint with the obligations of any other holder or holders of Existing PIOs or other preferred investment options of the Company (each, an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;) under any other agreement related to the exercise of such preferred investment options (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Other PIO Exercise Agreement</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d;), and the Holder shall not be responsible in any way for the performance of the obligations of any Other Holder or under any such Other PIO Exercise Agreement.  Nothing contained in this letter agreement, and no action taken by the Holders pursuant hereto, shall be deemed to constitute the Holder and the Other Holders as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Holder and the Other Holders are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by this letter agreement and the Company acknowledges that the Holder and the Other Holders are not acting in concert or as a group with respect to such obligations or the transactions contemplated by this letter agreement or any Other PIO Exercise Agreement.  The Company and the Holder confirm that the Holder has independently participated in the negotiation of the transactions contemplated hereby with the advice of its own counsel and advisors.  The</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">4</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Holder shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this letter agreement, and it shall not be necessary for any Other Holder to be joined as an additional party in any proceeding for such purpose.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company hereby represents and warrants as of the date hereof and covenants and agrees from and after the date hereof until six months after the date hereof, that none of the terms offered to any Other Holder with respect to any Other PIO Exercise Agreement (or any amendment, modification or waiver thereof) relating to preferred investment options that were sold concurrently with the Existing PIOs, is or will be more favorable to such Other Holder than those of the Holder and this letter agreement unless such terms are concurrently offered to the Holder.  If, and whenever on or after the date hereof until six months after the date hereof, the Company enters into an Other PIO Exercise Agreement relating to preferred investment options that were sold concurrently with the Existing PIOs, then (i) the Company shall provide notice thereof to the Holder promptly following the occurrence thereof and (ii) the terms and conditions of this letter agreement shall be, without any further action by the Holder or the Company, automatically amended and modified in an economically and legally equivalent manner such that the Holder shall receive the benefit of the more favorable terms and/or conditions (as the case may be) set forth in such Other PIO Exercise Agreement (including the issuance of additional Existing PIO Shares), provided that upon written notice to the Company at any time the Holder may elect not to accept the benefit of any such amended or modified term or condition, in which event the term or condition contained in this letter agreement shall apply to the Holder as it was in effect immediately prior to such amendment or modification as if such amendment or modification never occurred with respect to the Holder.  The provisions of this paragraph shall apply similarly and equally to each such Other PIO Exercise Agreement.</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">The Company shall pay all transfer agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of any Existing PIO Shares.  This letter agreement shall be construed and enforced in accordance with the laws of the State of New York, without regards to conflicts of laws principles. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">  </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">   </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">5</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:44%;box-sizing:content-box;"></td>
     <td style="width:11.9%;box-sizing:content-box;"></td>
     <td style="width:44.1%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Sincerely yours,</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;font-weight:bold;font-kerning:none;min-width:fit-content;">Arcadia Biosciences, Inc.</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td colspan="2" style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">By:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;border-bottom:1.5pt solid #000000;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">  </font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Name:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Title:</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
    </tr>
   </table><p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[Holder Signature Page Follows]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">6</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Accepted and Agreed to:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Holder: ________________________________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-style:italic;font-kerning:none;min-width:fit-content;">Signature of Authorized Signatory of Holder</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">: _________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Name of Authorized Signatory: _______________________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Title of Authorized Signatory: ________________________________________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Number of Existing PIOs: __________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Aggregate PIO Exercise Price at the Reduced Exercise Price being exercised contemporaneously with signing this letter agreement: _________________</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Existing PIOs Beneficial Ownership Blocker:  </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 4.99% or </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 9.99%</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New PIOs: _______________ (200% of the total Existing PIOs being exercised)</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">New PIOs Beneficial Ownership Blocker: </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 4.99% or </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Segoe UI Symbol',sans-serif;font-kerning:none;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> 9.99%</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">DTC Instructions:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">[Holder signature page to RKDA Inducement Offer]</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">7</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Annex A</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Representations, Warranties and Covenants of the Company</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">. The Company hereby makes the following representations and warranties to the Holder:</font></p><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">a)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">SEC Reports</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the one year preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">SEC Reports</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;). As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Exchange Act and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company is not currently an issuer identified in Rule 144(i) under the Securities Act.</font></p></td>
    </tr>
   </table><p style="margin-left:10%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">b)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Authorization; Enforcement</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this letter agreement and otherwise to carry out its obligations hereunder. The execution and delivery of this letter agreement by the Company and the consummation by the Company of the transactions contemplated hereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, its board of directors or its stockholders in connection herewith. This letter agreement has been duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors&#x2019; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">c)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">No Conflicts</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">. The execution, delivery and performance of this letter agreement by the Company and the consummation by the Company of the transactions contemplated hereby do not and will not: (i) conflict with or violate any provision of the Company&#x2019;s certificate or articles of incorporation, bylaws or other organizational or charter documents; or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any  liens, claims, security interests, other encumbrances or defects upon any of the properties or assets of the Company in connection with, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any material agreement, credit facility, debt or other material instrument (evidencing Company debt or otherwise) or other material understanding to which such Company is a party or by which any property or asset of the Company is bound or affected; or (iii) conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company is subject (including federal and state</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">8</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">securities laws and regulations), or by which any property or asset of the Company is bound or affected, except, in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a material adverse effect upon the business, prospects, properties, operations, condition (financial or otherwise) or results of operations of the Company, taken as a whole, or in its ability to perform its obligations under this letter agreement.</font></p></td>
    </tr>
   </table><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">d)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Registration Obligations</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">. As soon as reasonably practicable (and in any event within 30 calendar days of the date of this letter agreement) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Filing Date</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;), the Company shall file a registration statement on Form S-3 (or other appropriate form, including on Form S-1, if the Company is not then S-3 eligible) providing for the resale of the New PIO Shares by the holders of the New PIOs (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Resale Registration Statement</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;). The Company shall use commercially reasonable efforts to cause the Resale Registration Statement to become effective within sixty (60) calendar days following the date hereof (or within 90 calendar days following the date hereof in case of &#x201c;full review&#x201d; of such registration statement by the Commission) (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Effectiveness Date</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;) and to keep the Resale Registration Statement effective at all times until no holder of the New PIOs owns any New PIOs or New PIO Shares. In the event that the Resale Registration Statement is not (i) filed by the Filing Date or (ii) declared effective by the Commission by the Effectiveness Date, then, in addition to any other rights the holders of New PIOs may have hereunder or under applicable law, on the Filing Date or the Effectiveness Date (each such date being referred to herein as an &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Event Date</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#x201d;) and on each monthly anniversary of such Event Date (if the Resale Registration Statement shall not have been filed or declared effective by the applicable Event Date) until the Resale Registration Statement is filed or declared effective, the Company shall pay to each holder of New PIOs an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 1.0% multiplied by the aggregate exercise price of the New PIOs held by each holder of the New PIOs.  If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the holders of the New PIOs, accruing daily from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the Resale Registration Statement being filed or declared effective, as the case may be.</font></p></td>
    </tr>
   </table><p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">e)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Trading Market</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">. The transactions contemplated under this letter agreement comply with all the rules and regulations of the Nasdaq Capital Market.</font></p></td>
    </tr>
   </table><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">f)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Filings, Consents and Approvals</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by the Company of this letter agreement, other than: (i) the filings required pursuant to this letter agreement, (ii) application(s) or notice to each applicable Trading Market for the listing of the New PIOs and New PIO Shares for trading thereon in the time and manner required thereby, (iii) the filing of Form D with the</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">9</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">Commission, and (iv) such filings as are required to be made under applicable state securities laws.</font></p></td>
    </tr>
   </table><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">g)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Listing of Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the New PIO Shares on such Trading Market and promptly secure the listing of all of the New PIO Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the New PIO Shares, and will take such other action as is necessary to cause all of the New PIO Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&#x2019;s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</font></p></td>
    </tr>
   </table><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">h)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Subsequent Equity Sales</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:10%;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4%;word-break:keep-all;display:inline-flex;justify-content:flex-start;">(i)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From the date hereof until forty-five (45) days following the Closing Date, neither the Company nor any Subsidiary shall (A) issue, enter into any agreement to issue or announce the issuance or proposed issuance of any Common Stock or Common Stock Equivalents or (B) file any registration statement or any amendment or supplement to any existing registration statement (other than the Resale Registration Statement referred to herein). &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Exempt Issuance</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means the issuance of (a) shares of Common Stock or options to consultants, employees, officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose for services rendered to the Company, provided, however, any such issuances to consultants shall not exceed, in the aggregate, $50,000 of Common Stock or Common Stock Equivalents in any calendar quarter, (b) securities upon the exercise or exchange of or conversion of any Securities issued hereunder, and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations) or to extend the term of such securities, (c) preferred investment options issued to the Placement Agent in connection with the transactions consummated pursuant to this Agreement and any securities upon exercise of preferred investment options to the Placement Agent, and (d) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested directors of the </font></div></div></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">10</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;text-indent:54pt;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><div class="item-list-element-wrapper" style="margin-left:10%;text-indent:0;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4%;visibility:hidden;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;"></font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Company, provided that such securities are issued as &#x201c;restricted securities&#x201d; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in this Section (h)(i), and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></div></div><p style="margin-left:6.613%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:10%;text-indent:0;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">From the date hereof until the one (1) year anniversary of the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company nor any Subsidiary of Common Stock or Common Stock Equivalents (or a combination of units thereof) involving a Variable Rate Transaction. &#x201c;</font><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Variable Rate Transaction</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#x201d; means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement, including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price, regardless of whether shares pursuant to such agreement have actually been issued and regardless of whether such agreement is subsequently canceled; provided, however, that following the expiration of the prohibition period in Section (h)(i) above, the Company may enter into and effect sales pursuant to an at-the-market offering facility with the Placement Agent. The Holder shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</font></div></div><p style="margin-left:10%;text-indent:0;font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p><div class="item-list-element-wrapper" style="margin-left:10%;text-indent:0;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:4%;word-break:keep-all;text-indent:0;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">Notwithstanding the foregoing, this Section (h) shall not apply in respect of an Exempt Issuance, including a registration statement for an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance other than an Exempt Issuance pursuant to part (d) of the definition of &#x201c;Exempt Issuance&#x201d;.</font></div></div></td>
    </tr>
   </table><p style="margin-left:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p>
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">i)</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline solid;font-kerning:none;min-width:fit-content;">Form D; Blue Sky Filings</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">. If required, the Company agrees to timely file a Form D with respect to the New PIOs and New PIO Shares as required under Regulation D and to provide a copy thereof, promptly upon request of any Holder. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the New PIOs and New PIO Shares for, sale to the Holder at Closing under</font><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;"> </font></p></td>
    </tr>
   </table></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">11</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:1in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;">
   <table style="border-spacing:0;table-layout:auto;width:100.0%;border-collapse:separate;">
    <tr style="visibility:collapse;">
     <td style="width:0.991%;box-sizing:content-box;"></td>
     <td style="width:3.805%;box-sizing:content-box;"></td>
     <td style="width:95.204%;box-sizing:content-box;"></td>
    </tr>
    <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;"><p style="margin-top:0;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p></td>
     <td style="padding-top:0in;padding-left:0in;vertical-align:top;padding-bottom:0in;padding-right:0in;text-align:right;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-kerning:none;min-width:fit-content;">applicable securities or &#x201c;Blue Sky&#x201d; laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Holder.</font></p></td>
    </tr>
   </table><p style="margin-left:3.333%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">12</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>rkda-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!-- DFIN ActiveDisclosure (SM) HTML Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2026-01-13T20:05:52.7914+00:00 --><!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="padding:8px;margin:auto!important;z-index:0;-webkit-text-size-adjust:100%;position:relative;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.7in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Exhibit 99.1</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img192114479_0.jpg" alt="img192114479_0.jpg" style="width:128px;height:93px;"></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">DALLAS, Texas (January 12, 2026) </font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#x2013;</font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></font><font><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Arcadia Biosciences, Inc</font></font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">.</font><font style="color:#1155cc;white-space:pre-wrap;vertical-align:super;font-size:7.37pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#174;</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that it has entered into definitive agreements for the immediate exercise of certain outstanding preferred investment options to purchase up to an aggregate of 808,595 shares originally issued in December 2020, January 2021, August 2022 and March 2023, having an exercise price of $9.00 per share, at a reduced exercise price of $2.575 per share. The shares of common stock issuable upon exercise of the preferred investment options are registered pursuant to effective registration statements on Form S-1 (Registration Nos. 333-262407 and 333-267637) and Form S-3 (Registration Nos. 333-252659 and 333-271082). The gross proceeds to the company from the exercise of the preferred investment options are expected to be approximately $2.1 million, prior to deducting placement agent fees and offering expenses.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">H.C. Wainwright &amp; Co. is acting as the exclusive placement agent for the offering.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">In consideration for the immediate exercise of the preferred investment options for cash, Arcadia will issue new unregistered preferred investment options to purchase up to 1,617,190 shares of common stock. The new preferred investment options will have an exercise price of $2.325 per share, will be exercisable immediately and will expire thirty months after the effective date of the Resale Registration Statement (as defined below).</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The offering is expected to close on or about January 12, 2026, subject to satisfaction of customary closing conditions. Arcadia intends to use the net proceeds from the offering for working capital and general corporate purposes.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">The new preferred investment options described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the 1933 Act) and, along with the shares of common stock issuable upon their exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (SEC) or an applicable exemption from such registration requirements. The company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new preferred investment options (the Resale Registration Statement).</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> </font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">1</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
  <div style="padding-top:0.5in;z-index:2;min-height:0.7in;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;margin-left:0;margin-right:0;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p></div>
  <div class="main-content-container" style="z-index:5;position:relative;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">About Arcadia Biosciences, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in agricultural innovation, Arcadia cultivates next-generation wellness products. For more information, visit www.arcadiabio.com.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Safe Harbor Statement</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include those that express plans, anticipation, intent, contingencies, goals, targets, or future developments or otherwise are not statements of historical fact. These statements relate to future events or future results of operations, including, but not limited to statements concerning the following matters: the completion of the offering; the satisfaction of customary closing conditions related to the offering; and the anticipated use of proceeds from the offering</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">.</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;"> Forward-looking statements concerning anticipated future activities assume that the company has sufficient funding to continue its operations and planned activities, which may not be the case. Arcadia will require additional funding to continue to support its anticipated operations and planned activities. There are no assurances that required funding will be available at all or will be available in sufficient amounts. Forward-looking statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause the company&#x2019;s actual results to be materially different from the results anticipated by such forward-looking statements. Undue reliance should not be placed on any forward-looking statements. Risks and uncertainties relating to the company&#x2019;s business and future prospects also include, but are not limited to, the risks set forth in filings that the company makes with the Securities and Exchange Commission (SEC) from time to time, including in Arcadia&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2024, as amended, quarterly reports on Form 10-Q filed with the SEC, and other filings that the company makes with the SEC, all of which are available free of charge on the SEC&#x2019;s web site at </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">www.sec.gov</font><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">. Any forward-looking statements speak only as of the date as of which they are made, and except as required by law, Arcadia Biosciences, Inc. disclaims any obligation to update forward-looking statements or to reflect events or circumstances arising after the date of this press release.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">Arcadia Biosciences Contact:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.667%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">T.J. Schaefer</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#1155cc;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">ir@arcadiabio.com</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">###</font></p></div>
  <div style="z-index:2;flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;position:relative;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;margin-left:0;margin-right:0;"><font style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:Arial;font-kerning:none;min-width:fit-content;">2</font></p></div>
  <hr style="margin-inline-start:auto;margin-inline-end:auto;page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img192114479_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img192114479_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" != ( # 2(  A$! Q$!_\0
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M3^BW_!1;Q^V@?"WPQX MIVBN?B3XHC2^56 +^'?"H@UC4(W&<^7/JLF@PO\
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MC7KW3;FVT?Q#)H-S=6-OK::+J$MOJ3:1<7MG!J2VQLY;JWCF:5/QN_X(Z_\
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M_AY/$,6J7_@KP1XQLKOQ=\-EM?B'IWB3P%K.M:O%X?\ $-OH=TVB4 2^.?\
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F@FVU&/-*4N6.RYI2E9*\F[LZ$K)*[=DE=VN[=79)7>[LDNR1_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>rkda-20260109.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2026-01-13T20:05:53.4460+00:00 -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://arcadiabio.com/20260109" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:rkda="http://arcadiabio.com/20260109" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" namespace="http://fasb.org/us-gaap/2025"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk">
        <link:roleRef roleURI="http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rkda-20260109.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
        <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
          <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
        </link:labelLink>
        <link:presentationLink xlink:role="http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
        </link:presentationLink>
      </link:linkbase>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Jan. 09, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jan.  09,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Arcadia Biosciences, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001469443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-0571538<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5956 Sherry Lane<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dallas<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">974-8921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RKDA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="rkda-20260109.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="rkda-20260109.htm">rkda-20260109.htm</File>
    <File>rkda-20260109.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rkda-20260109.htm": {
   "nsprefix": "rkda",
   "nsuri": "http://arcadiabio.com/20260109",
   "dts": {
    "inline": {
     "local": [
      "rkda-20260109.htm"
     ]
    },
    "schema": {
     "local": [
      "rkda-20260109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rkda-20260109.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "h2",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rkda-20260109.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://arcadiabio.com/20260109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-26-012028-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-012028-xbrl.zip
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M$(.=C,0I.2D+<C2@H-/RO4>&+^YK]F_Q];7BZ^8:Y^9RVWR.1?^ ;Q[6D/>
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MXM,$>I!,\0O;^9/IU*^!S305E!2X5A7<(LX6<18A#DV*K'*E@=L:O*I$&T
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M/$FU-T0FO^'S!=:EW!@R388%B(H!BV0$.I\ZI'A0L A<+7!,ZW ,N%9D%]>
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MALUQ7L678KB%$!^1<QM"]T7.9FU==,GYS%"KA>M@.F ,JV5);5;_GHHZQ%(
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MR//M8N.;6VQ\MQ]D;/+A#^_V!^4P^?#_4$L#!!0    ( .>@+5R$'"H9B @
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M4< 3@1_!Q%,)$^*0,R41:SZ',[(#HI>YD2=7\"#]=@?HD]3G.].&0\59I40
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M&[;5)PQ)[;"=6@S?9P;$V<KF@TB/F0XS;&: D435621!G#(A*$0/'^2&0)?
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M)U7*L-F03-/JAHU1RM8GX)R?CV"@'3[DD0++-\S\VX2=4>6<9TSH]Z9)C-8
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M XRM56KV\JI-9(=1;L' G@'A_,@4UZ3!D1K,!!%#]J86W#5OM8'/1*['JN1
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M?C7@+8TBX3/W%8Y0TPU_LS=LGWU9)3.Z)T6D:%1$]*C2+_RE,QF@-KB<T-
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MG<*3OP[<[)<\J:S6!.@V657CL P+-IFMH'P*H@&RG%GBQ'!X3K4^(GY;N":
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MG:V0*>VPE]<)YIE6JZ:R]#6/#I+M"_K-=UFH"<QO>>=7XUTHLYS=Q3IH5OA
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MEFV<IK,7]XZD>.*7ZZU[.F'+@5:*[=?@L$ZH?%9&(*RSM0Q8K02BZNM=!ZO
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ME''.)0I;I/?#!?GBX"&Y()^M1@5YYQOODRC.65XT$TV]VG3FN"_<-RL[G$J
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ME 3QC**>.$4W\!YS44[1@[4ETTC!P0PS."<9E4Y50H\$0PTG*H!#$,8_(QB
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M.2*4@QEVZN.;MUZ03LE?.XD*Z:?:1<V%U';YTR\*/Q@S4E/&ZCPMA%3--%/
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M)F"*;PZ+[K3"UFN%#TDMC%.]M5ZGZ>>VZ8*N "'4&8;1N'PEFGPY^IPD<WJ
MS6?2' 2 ,!:$1" R08C.!0W&0R(WJ0LL2M>V=?N;^ZBVO(#6O<RLZMW6>?]=
M-DDU]&2.G7>65J1E&Z?I[,6](PE]^.5FZYY.V')\D4+:-12H$R&>EP/OFVPM
M@]$J88?Z>M?!*C"Z'H.7)$ K_=/^&F.E\46V;3FF6N*I78QU=N/2-.@2T\-.
MD8X4J0\&#U%=(L>@/<48XQ5J&!N=_*BR'./DZ$CB#%[?&V4IN8F:G^J)OK6
MK,Z^2@A$Y W;F<-[7!19-.!BUA^9CKE-6\L@D7I]4R<S4:@I4]V9](;<AXCG
MR4WRQVMSA??A!LZB?!Q-'=%1*J8^4'%ZTQ/HA.$+,?4G,C5*7;! ?SWH1[6-
MC78#'JC.6L*O&B;#I(M@6$JM]_JOJ"/:S&W"2$7AR.=!C#1#-;J!^AXT6EH*
M<[%^2_GQ>F+;M/"ZFG,=4N%.&O/BL2(5'GW-N;(81N1[-5#/5"$$-L GF=3R
M#=2XU6>-U68J)P[\T'3@&-HEV]H,W5C7<)(ZH,Z9TU[T8:<)7U.4VV\5L=S6
M9RC#U1R0[P+0A7E&^?0X-;C1O$*F9._VN(B!:;RKE"9^G([2F?%@.7?IU:X)
M6NY\F$'E./V"A5W*NK&X5NLP1>8O*FLHI7(,F%Y@&TE-9,W'^#X#/PYFL2_U
M:Q95U3@XQ,(Z,D/0Q+&?C!16U##.SFP6RS(!]0@?R#2/63J9Q2-Z?.$@_Z)"
M% 6GR$=U[&I8:2FA5 JG5R&X< OI);I;HI40@!IAM+?IFDW" )4;G16H"D'O
M#!TF67?H':8Q<%&B \RCB&MC2T.!K4 C\:IN32U<=[02*C.L2Y])T;*20D9Q
M+B6>]%7%W@VPF.33#H7;9 B1";FV7QO6>]EZPG%9K<SVF+931^0V$7.5)MMX
M&V\8G"X/5*X@4TTH=3V_("0D<X ][PVN[2H>7!C0&PS!1SS^1,%&Q&""J#>R
M=PT#K%\+FS@D*TGJPKOA@2"YX4R7,X@RE<AY$,#@^('-6RU-!NXU)XN.87ON
M9/D&0,.N $Q=F%$(EHYO$!\DQSA3S5D1IDK8-Q.@C:9I3?!'B6F<QI9;V\LE
M(FNVP_K6U<01K-C0R6WR& 87#FV--"%RK^,<W?IO3+P5!7R")@C_X3IO(D^-
M=^;$I/WTF8A-LNTX:M[G7!5X-/'W\J-GL)0"?&HZ@WFB]5RI3XOTR"?5^RJH
M_?HM13V7$JG$"/5%Y_A:UJ\SHC#-GS083+\=/7$9C4:-1:B))U&8.)MH-_7.
MP<?%7&474V*RJ/%@72NWI5RS3K)6H2TX(U4OR1HKIVF/+7 TTKPW:W38X$5:
M9M]">]?PC=9TN_5TYSS2&264U^F[Q?@(\;')F-PX93XE-K.-'L85IT&;;'5#
M%6B6X].]ER__K%=2T[;0@JEI4Y<RCY:LYA*VZ:Y=>K)RM-R@^T6N5<M)3BBA
MDWA&%2>_R=_K>%7+.=\-9U29FWB=1T;84H&9Z)3-ERV9D,U=JV,5+X*/K!@[
M7<PG14-HQK70P1"8(Q(X<:9,=.%5PVH"NX@#-J55F)H5[W]^<,L]B=8_,A>)
M.R:?P='N;-07>_M/]YW_#NYLW^9%FZ2(%Y9)<G7N7^Z0V9:WGNS1AF4P]3-_
M!"VUQ5Q;U=/.2=XYR>^B,2\[)_DC=9+#7WF1(1Z4K!),7<=#4^-#!4UD<U<T
MUPK<%,&!C98-P@6+N;43&2+4>)!2%GN6T5%?%J\[XMS3/A%&&/5$>=? ;*5/
M2T)Q8]NQ3$Q2V)=CH6]D#UAY"HM?V3K\THS9RC]3!>)D)'E%LZD,2>XE"L/<
MR"Y-RED>93K9&DX..&M!J1EAXRJ@#.M>Y*1UMSA/W=]8/7%(TV"O.M5ZSW-X
MN:V>L3X_H5LCV 5BM72U?Q]&=5W:NDW">6^KP&,GH(0BV_^Q24%K%:"EM!^Z
M\M#M+0_M/YSRT&RQOHF(%"1DS_/E-(Y:MC,J[)V4:*K)<? <CM5:80K'WC^B
MJ/L4"P7Y#%[V0AF%$LZ13EV\)L3JHMJIAX>L\SE'E[CU!J!#L.QGR)Q M; )
MI.8OA^/(<5%JXI<H6>1GV"$%A*.__G4:A=HO$::S0=%WH*$:(B8>X45>)%5-
M=-O<E='K,T @GPUX./-UW)F@&5%H'A,%LYKKAAX)SPS2R0"V0UYB_D+R+ KU
M()P<LV)X+G-<P[T-WIU/D-&Y_G** D37/1X@JJ (.B(*9BX=*$&R)4ZF\J '
M_C3"S!QN9M4/3<[S4ORLJ.<SVS3+4N:S7\KXMIG>T",%(B5URJ*MY<C?8;@>
M.<71B33+YF9"-+/:(@>:$"=RPC@YZ4K110Y1)RD%W39NV'*OG7VG#2;6'OD5
M,$B;& J*-5L$\GK2*I0DAAI/YD*JR?5?QE@@;Y:P\A^*<\_)I*>$VW(^A&/?
M'.[X/=-N*G-G?7OU 63T$16^HTB%9L^KQ;2=E(^\Q!H@%> D^NI(U9(,I1S:
M31IE?Z=VU5@U1>9P%)"%A:^E=2:5PP]>E??NW:9X=;K7O>M>@P>D>\T&.<9O
MH:7,F.Y]@!6.:8\M4[Z::(>M\&DF.B>90R )/BT<?<U5,$89W(<'"I^N>!:H
M.,[IXD6 /MK//& N14G.<(4;/Y-GNO%>32C WI""<ED]F&R?^A/'KM33(DT@
MBB0)EIV3Q99&7S_JD6L?7W\3RZS+>%^AJ?$#R:LVK#GLZ'/RB+3'J]+I?N6,
MKOQ<)\P)+&NGO#6LT&DB@2<%]-929O@A5A<A@"*<M)LI)3L:&XO=R$*]25UW
MGJOGL ?3A3TT86O7"!CVFK0^@W%(-;>JK[<6UI$&>RHQ2@7M_[X35<V8ZM-0
M>52G*V4R\T2FL_+<?C/ HGES+YH1PT;@ $X:VKNRL0^BB+1TY4U)^6MMN6AO
M9YO&MB-">;A$* W9L4U 84N=J\O,LF5#3H.Z3)%\.!!;8/IK"TC.'8;!:(SG
M2J!M]5RUWJ(J!URY94VMLA60J;<[5#JA(=] "\K%&%%?]ZU9IE;>U'.(F):V
MR!CM=##C^ [4G X<+=AE%"S4I5*RG(UZ6!5T_."B(Z0INOID#H43AF>H(S7N
M4!!W*54.]A\K#.)KG3'?UO/2>F)CSIWZVN/#9@(68Z0\!AE>C'/'5[=0;>SM
MM6E;-<KISOW77O=?\'#<?Q^SU+M #]0;-Y+8IMVQYWEO9D3#9K0?SJ[9*-):
M*S[&REB(4;2,C&@"-N$OM0AL)>K*H578F0JMZY(;4)PQS@4][=I;P^0G.C[<
M\OU21+&898D;M"L%AM=)3:XV'QF0^SKVE]6R^?K6/XF_2IUTVR+?C! \9(H9
M/<-AOQ:/[!O6//1ZD#MT1,*K3_FIS*#H?.VT1&CUG()AO6TMG>7NJC9M*L>U
MZ3K%[='I9ABLSD9",\ZF7$K6<X4DR5@_J\PZ=\RT!8M4B@O,6+>$D?,XR5&$
MAW:.T06.T>%2QVAM+KZ[V]/.KB3?U)=+YWGK/&_?>P!1/C42TUDI]!]K^-Q*
MZ[HE'K>J:*[ZVZ1EB]QN2Y!?35ZW)6_KV=0TRQ%0OVFUQXV;:EC<2PZX#;UM
M=V/4]CHPR)99@^$ZUJ 7A7_Y8QJK_X6/GY]OB7'X%M[BXQ+SA:";M?$VB5L$
MY=X!$+=/[O42"I*]X/&<4VGT)])RD<( +49F9& J#L=:R04DQ@"2B2(\*?.#
MT&09[)IKCU*"#KV*M$.7&[2OG5P.(Y5D_"-Z)P(%+V/2'5+>2)1269G>XEZX
M+<3P<=^+%6GLA+?,$=\61P%6H4"9IPGH^X;CO<\4!W,=+S>&LG:?DKRG J\(
MB<-Q+IB;2FI>.#:T'5$?S-!,J!&:!K94T-J<E)6W.C!7/F$,RO68Z%+>IBDN
MB%&&12$1R7.6!'L:WNM,O3MD?:>XYY"Z3UE4&7]BC@<A4N%O=C373IV;HSRY
MB.DU9D6YY!GKSX[27%.5IZ@B%P4?V(A9LNUR6@1OBTR!MF&CQ4]%D5('F83'
M*W27B\+Z 1*!66"VTZ0)FQ0P'<_V3=J[BXVM0M ;;[A.B>AC"NJ<J<0MDZ>!
MZA6,,J&A[V6_UAT98(UE(S^)_ND .<498[YKRNMGO#W.[2S.4PU<MO-2G^O:
M,Z+< DZI_JYFL",QX4QRN.;$]@E*7AZ[DCQWSZEG&$MICZS_NCEN4T_P))A-
M)DR%93UQO#Z,I/%!1%5\8P,0S0E2";O(XI4^P,H*[M?6+SOR=D%T<:FX!O]<
M3_-XN<(+KV:"*KA8$UG?H%8\$-G<?+7X2?/5XF,1^OZ.!(FW0QZK[70N;H%Z
M5H%0"C:23VZ#.W9]:1UDH8,LW"EDX:"#+'20A3M82&L%0<I.M7HM#,E)XFQ)
M.GE6UG]BUZ$3XR"-O)PZ5BJ)6O+Y3[.(:1OH7$5.RDRY10H7'"%D4=,MTSI;
MZ>IP!NIC)5J+=/,JLKTU2QE(TRSU ZK=I%Y4*W>E6<V*B- .I0 &/2*[9K(M
MYRY;K4/GGOA$= 56MY+G;FWJQ7$,\@OS!F% G ZU27Q;3#5O'5KS3;[B!0N9
M4U)=-I UEA1N3FV/;4:4V[CUEK;OV^RE!I)6XSTIEU*NY5<N2_V%,P3,RBRJ
MI)YJ^C?3^04+S1OX1,XNY7:XOC*Z:19<;H1>N?HJ6GYL.=6SJE=)N4:>7VB\
M!!4:.@_-%$?^PF8FM#Q]L'BHM4(1),2S.@R@CVKOVH]G2L](&*'W"&<.W0;0
M,\HT&RY['V;&#9=ZB9!S1\A/QRGUP3#*+_4!<2!6SBSA.UHXE,UQI8%^NPGB
MUYJP<!@+_>K<6@T;A=V':1RG-P8YM*#I5#.]P&UHC$YX$U+5&N99E$>9G[&C
M@38?99,3%F;1QHYTVA$H0V/C77:FR3%7%U<>X$#ZYF)%4RCVUQR$1:X5*F"T
MS-*N-]T>HQ1-I =>FM/YE+^KESCB<J0F5:[O@CMKO/OX5>V9F-J=*K[ 4%'*
M64$;&C/U,64*XWN:2;C$?[VS$_7,>^\D6XI.NAO6_0<P]_=S2KZ>S7<'/NSV
M$UW,M54(OK(3H.P*GZ^S-EB8&*6TFKZ2B@+NGL1N1 A:PHHO+FC<Z.0$%3KJ
MPWVDPQ34<%]O=_;..4?@PO-;,#'H<,P<!(S<UD3P+3\Y::$+'MYSH@ZKA5V6
M3ESY"XK/U)_7Z;,Q<&).6A+YZA](::ZI\6-<1Y<!AH]R[U<ZFQHF)*W4ARE5
M6]F$ME\.67?,JL._3&Z],JR]?4_ (!J (;"OAKWAV%$YO"4?1L+NA[3DRR9;
MI(^L'&<M_P<3U65I[**V\%I2D:YKG#9PP^L4]3WHWQN2M6F6LV_^26_IL:@9
M>6"^*H=)C<1^$UW($ZY >IJX2NNRO;Y7)0Z)'##HSD;4"#F+N1(CG!O_F*4%
MDP>B X+5/2RKS:8453 )TE$"(B=T7ZCC&J)8E)2*-"$T6R/;A]D&JZ2,44B*
M^90B!TC3R$'#DG$G7/3F<DNXTC,"J6G3I/4J1!L5O^1"YKJ('045995._<CP
M\RY2^RIJ!/,X)DHK!\(%N5 9L(5"_*(R(+:DB1FP,IQ88EXF.E%H."-95?JY
MBYMN-582!JPN5F>8M7!?]@A]G0JI9E!5QC?HN2M.AK,,VZIG8K&*7579,BP2
MTB["Y\ZKWGG5[]2K_J3SJG=>]3M82/I<0[<#'FM\>%0$^')+%X^7332]/C]O
MD337S"ZVNA8]PWA!JIBB9K6(3?_:]T+3[!X7Z]GGO57CL.<94[5!&S%U0R8*
M[F#[W6HIJPHXNEXZ>OBN?KA<@9XQ[,'[-%2@G@V$L=GH8KIE'WXU#1F".:0-
M@-=QFJ)+=E0JKF.4SI#3CIJLLM4V%%<EE/89_R>7MC+^."P#Y7M9E'_>'6(B
M*7)D9UC1B+*7B) ;J^R%CC7U:>]R#]XCC(29IJCSI5I4V:@B*W2@BANEZN;.
M5YF(QH-Y5<EPE6I3F%4RY7)7URE*L5BX/KEQ!_O[?^Y3?2G653'H0#;CE'R=
M4Z4Q*;.<'8"U@H8ETD28'].KR@/*:BQJ9:0U,H4CV+GQK+(L<6^ Z-@E$[4D
M$NQ=M8<NE11DX;VAF39FJ\2W:(*^]Y1Q T^Q@?]4&1+!<TTMT(:R](:IT<'Z
M<]_69'AH 49LC)BUAPF)&K99]2;ZUWX44VMA0X:<SNC@=DKCWG,-7_)W:%J*
M(2K@KS4TZ0VZ4TH10VN2JE@YDZ&]>WIL-W"\2$62LN,^\&>YTI$-D;SBA%SF
MO+:^V@6N1G9IHG'.$1-Z)!DTE:326B21A[/<%.,I-V%((WPQ<I+?A=_Q.U$)
MEH^[-FFL-I!(8PS+3+DEY@243"%O4]VQYHW7;N,5!Z;>X+R'W(7V)@UFS%;8
M4)^1Q>;"0DM4M;$$&94R? 8F2$\EJYP):0AU'2@;BYJ+%N2CNVE><PR&-6]5
M-> _2YRX%ISU_KRW9D#"\*PNA1;T=06B2MLPLU0[ZCES9]44:%_2?*&.IBB'
M.="TQ7HT(RKW0<\JX]9U6G+S&&NVVV6-8AE3"1FSUE#6,9HBU#7*9AKNA0XY
M]L.)R.FY[-XZ\K<RX965)!-UWYRD>+VTUXV#V>NM. X@"6;5OH#U$LE[Y6+%
MY1;P!::\J7G-HIG8&4 '"_\S19<H=P.V]2PI%@1YEPR]N[=7[J62KK2L@?UJ
M8<=%'3$D5I6A8"7+Y."R"HVW@Z@HG( V'#;(I1UL8%DL1"IM$@+HR4SKS;5(
MVBW9MUK.[-D:IV6LE %++ M_US<C:R6D -#ASBT=*'Y_5,P*P>WOY"F[&=FY
MF81.)KY6CE:_O^'P^-ICBF]W[!ZMEY2"#:8@)5U.(E3YQD=='1:9,+2%S5+#
MP,U<<'+DXW8!W,:S:KBZY0#_YJ>V.:>9CX#+&&%*Z")QC&P#Y'Y(_ D;M6[+
MF*"@_5Q$G:NX<Q7?VE5\V+F*NYSMMN5LJX?#X'5BO7&M0OWL><?DDK&M<T]B
M8]4ZA630824Z0Z)\<L &DOWF?G?PP\'^/B9+4[D-U&;[^F"E,ASL9-^K(5[+
M[UT37F[#  .ERQ-1%1DG1XU=U;Y$K4E?6^06O9-Z-\W-:.2-:"S?>7"X=WAX
M>%<5#??7D![?TL]S\'S_E7ODW%H,ZV$J:3+K2ET:CEU\87Z$ 122*-6!LYV0
M5[5)#A_NO7CZ[,=G3Y\>OGRZ_WP?A'&S)-Y8]@X?CNP]-W7JV8!LE_QMU.7O
MOZ#O@Q4(3_;+2MF+JAA]N$K9<^SJC\_N2A<36^J//T=[#T86V'JN* _*62/M
MD@N_C56BK@T OI3> BJ2R>-Q'9)4>EK[EQ9I4^5H'%P^F2+DNMFG/YA[&(:-
M$0W*8C1712&^1G&S5'-O;&T]I^R<3M#CC#!2R$I34=:[5B9<,CJ@W!;?&V21
MPF)SH-RY 5AT+J*73.<;5MJV=[?4SIT NGL!]( DD-5&CA%39'</;+4VZB=G
M0T+>U"6'9F6V3,,4U[+5:TN,QA2]AWV)(@8]_"9%TC6L& ^S[%683XBD?-#H
M#&.'G#^,Z!-+")TP215(#S4IA2\KKSII>I4_*\9I!J-(OU$-)W&L5_BAJP_4
M!-,(H):Z<APC&N0!C +'$-G8%>*8Y<5>G7IRF?Z<264K!,@(C@6DO1^;Z(=;
M9K/B8#?&+LM!P?=44-=-U$K-HZ<Q@ Y56J99U*I,21IUX1-=Y;QO^,S(:>"
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MOORSMP,&VTO\BSW/UB/8X%IQ1\@,D>UJ;OSR97KGLI\^G16F*(I;+'G):-(
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M,2YH=&U02P$"% ,4    " #GH"U<IBHN-"]2  #VT ( #@
M@ $O7@  <FMD82UE>#1?,2YH=&U02P$"% ,4    " #GH"U<+9,N MA1  ""
MN ( #@              @ &*L   <FMD82UE>#1?-"YH=&U02P$"% ,4
M" #GH"U<??3.LWX,  "-00  #P              @ &. @$ <FMD82UE>#DY
<7S$N:'1M4$L%!@     &  8 < $  #D/ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>rkda-20260109_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rkda-20260109.xsd" xlink:type="simple"/>
    <context id="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001469443</identifier>
        </entity>
        <period>
            <startDate>2026-01-09</startDate>
            <endDate>2026-01-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_016d44f7-8e4e-47fd-a84a-71dd3c120033">0001469443</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_1378254f-7a4b-48e6-92df-9bcbfc2b4d37">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_81558ed6-a658-4a6c-877a-e6e9697a2926">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_9fd45f20-e91e-4550-9a0a-847856062738">2026-01-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_1d8ab472-4064-4d86-8457-871634151034">Arcadia Biosciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_a04774ce-bd1e-4418-b50c-0302d95bdfc4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_c8f0e95b-9f5c-4c3a-8f91-ba5d9c083191">001-37383</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_d3efd588-8b83-4baf-838e-6b4fefb56853">81-0571538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_9dfee375-b870-4c5a-860f-e73583af113d">5956 Sherry Lane</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_ee8dd85e-2c7f-444d-87da-065ddb7d82fa">Suite 2000</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_55940f47-668f-41d2-a575-3afc441352dd">Dallas</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_6766d6d7-b6d6-4d76-9695-c821ce83fb7f">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_55baaddc-6ec0-45c9-8e9b-d72a977e7d9e">75225</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_b4f3aac5-e9ee-413d-9960-038811043e69">214</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_927d1112-d9ac-45d9-b3a1-8b6916b730a3">974-8921</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_e984d6a9-9639-4103-be95-f9063996651c">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_177ab029-9d2e-4aaf-9437-1399689656a5">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_1bb44dca-b500-4cb8-94cf-19609ab14f8b">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_4d3e5752-1ffc-465e-a4d8-26f8d69d544c">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_5b3c12e2-3a25-465d-92aa-cd0c4eefe82e">Common</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_965dbaae-557b-4a90-b144-6cc94be1c116">RKDA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_cb904015-1283-41d6-91bb-987b48763fcc">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_8e9d76b8-2f0b-4f60-bf52-22455c33fab4"
      id="F_1d1b879d-7fa0-4812-b324-688b41ebd0b5">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
